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ABSTRACT
The sale of small turtles is banned from the US market due to concerns about their
excretion of Salmonella spp. To produce a safe pet for the export market, the Louisiana pet
turtle industry uses 1000 µg/ml gentamicin sulfate baths to eradicate Salmonella spp. from
turtle eggs. In 1999, we analyzed bacterial samples recovered from turtle farms and found that
strains of Salmonella enterica subsp. arizonae and other bacteria such as Salmonella enterica
subsp. enterica, Enterobacter cloacae, Citrobacter freundii, Pseudomonas aeruginosa and
Stenotrophomonas maltophilia, were resistant to high concentrations of gentamicin (>2000
µg/ml) and to other aminoglycosides. The goal of this study was to identify the gene(s)
contributing to the high-level gentamicin resistance phenotype observed in bacteria from
environmental samples with turtle farming activity, particularly the salmonellae, and to
estimate their incidence in these bacteria, as well as to explore the molecular elements that
contribute to the dissemination of gentamicin resistance in this context. R-plasmids from
gentamicin resistant strains were transferred by conjugation and transformation to naïve
Escherichia coli cells. Cloning and sequencing of the gentamicin resistance determinants on
these plasmids revealed the presence of aminoglycoside acetyltransferase genes aac(3)IIa and
aac(3)VIa. Multiplex PCR assays showed that every gentamicin resistant isolate carried either
one of these acetyltransferase genes. Pulsed-Field Gel Electrophoresis and restriction enzyme
digestion analysis of R-plasmids carrying these genes revealed plasmids with sizes ranging
from ca. 45 kb to 145 kb, with different restriction profiles, supporting their presence on mobile
molecular elements. In effect, gene aac(3)VIa was present as a gene cassette of a class 1
integron. Furthermore, evidence suggests that gene aac(3)IIa may be encoded as part of a
complex class 1 integron. The presence of aac(3)IIa and aac(3)VIa in mobile molecular
elements explains the distribution of these genes in the different plasmids and organisms

xiii

described in this study. Further studies are required to characterize these molecular elements,
and to detect genes which may be co-selected in the presence of gentamicin. This work is one
of the first to report dissemination of high-level gentamicin resistance in Gram-negative
bacteria, particularly in environmental isolates of Salmonella enterica subsp. arizonae.
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CHAPTER 1: INTRODUCTION
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1.1 Background - Gentamicin Resistance in Louisiana Pet Turtle Farms
The pet turtle industry began in the 1930s, with the sale of hatchlings in the United States
pet market. In 1974, the sale of baby turtles was banned by the Food and Drug Administration
(FDA) in the domestic market due to concerns about their excretion of the human pathogen
Salmonella spp., etiological agent of Salmonellosis or “Salmonella food poisoning” (Siebeling,
R.J., et al, 1975b; Cohen, M.L., et al, 1980; Michael-Marler, S., et al, 1983; Siebeling, R.J., et al,
1984; Izadjoo, M.J., et al, 1987; D'Aoust, J.Y., et al, 1990; Shane, S.M., et al, 1990; Ebani, V.V.,
et al, 2005). In spite of the domestic ban on the sale of small carapace turtles, the export market
has continued to thrive. Thus, around 12 million hatchlings enter the export market each year to
Western Europe, South America and Asia (Japan, China). The economic impact of the industry
in the State of Louisiana is estimated around 30 million US dollars. The main geographical areas
in Louisiana where turtle farming occurs are Pierre Part, Jonesville and Ponchatoula (Figure 1.1)
(Siebeling, R.J., et al, 1975b; Siebeling, R.J., et al, 1975a; Michael-Marler, S., et al, 1983;
Siebeling, R.J., et al, 1984).
In order to eradicate Salmonella spp. from turtle eggs, farmers follow a modified version
of the protocol used in the turkey industry to treat eggs, the pressure-differential egg-dip
procedure (Saif, Y.M. and Shelly, S.M., 1973; Greenfield, J., et al, 1975; Nivas, S.C., et al,
1975; Ekperigin, H.E. and McCapes, R.H., 1977; Ekperigin, H.E., et al, 1983). This modified,
FDA-approved treatment is summarized as follows: 1) Every day from April through September,
eggs are picked from fresh nests; at this point each egg harbors approximately 10-75 million
bacteria (Siebeling, R.J., et al, 1984). 2) Eggs are immersed in a Clorox bath at 380 ppm (1
oz/gallon) for 10-15 min.; this sanitation step reduces bacterial counts to 10-50,000 per egg
(Siebeling, R.J., et al, 1984). 3) Sanitized eggs are treated in baths of gentamicin sulfate
(Garasol; Shering Corp., Bloomfield, N.J.), at 1000 ppm (1000 µg/ml), using the pressure2

differential method (Siebeling, R.J., et al, 1975b; Michael-Marler, S., et al, 1983; Siebeling, R.J.,
et al, 1984). It is mandatory in the State of Louisiana to treat eggs with this antibiotic in order to
eradicate Salmonella spp. Gentamicin sulfate was chosen for the treatment of turtle eggs since it
presents various advantages at a commercial turtle farm; notably, it does not lose its

Figure 1.1: Distribution of Pet Turtle Farms in Louisiana

antimicrobial activity when in solution or when exposed to freezing or auto-claving
temperatures, allowing it to be reused after appropriate readjustments are made (Michael-Marler,
S., et al, 1983; Siebeling, R.J., et al, 1984). 4) After a 60 day incubation period, turtles hatch, and
before they can be exported, representative samples from each farm must be tested for
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Salmonella spp. This test, called “Certification”, is done by independent FDA-certified
laboratories; it involves the enrichment, isolation, and identification of Salmonella spp. through
classic bacteriological and molecular assays (Siebeling, R.J., et al, 1975a; Michael-Marler, S., et
al, 1983; Siebeling, R.J., et al, 1984).
S. enterica subsp. enterica serovar Enteritidis is the major cause of Salmonella food
poisoning in the U.S., since it is a frequent contaminant of chicken eggs (Cohen, M.L., et al,
1980; Carattoli, A., 2003). Salmonella spp. is a mesophilic, Gram-negative, motile bacillus,
bacteriologically characterized as a non-lactose fermentor, H2S-positive, lysine-decarboxylasepositive microorganism. S. enterica subsp. arizonae, which commonly inhabits the cloacae of
reptiles, can be readily differentiated bacteriologically from other salmonellae since it is a
delayed lactose fermentor (Siebeling, R.J., et al, 1975a; Siebeling, R.J., et al, 1984; Ebani, V.V.,
et al, 2005).
It is well known that the use of any antibiotic presents a life cycle where resistance to the
particular antibiotic will generally follow its implementation or use (Davies, J. and Smith, D.I.,
1978; Levy, S.B., 1998; Mazel, D. and Davies, J., 1999; Levy, S.B., 2002). Gentamicin
resistance in Salmonella spp. isolated from pet turtles was originally reported in Canada, in 1990,
a study stating that turtles exported from Louisiana to Canada carried gentamicin-resistant
Salmonella spp. (D'Aoust, J.Y., et al, 1990). Concerns of the emergence of gentamicin-resistant
S. enterica subsp. arizonae, which could survive gentamicin treatment, had been previously
reported in the turkey industry (Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). This
gentamicin resistance problem was later addressed at L.S.U. in collaborative work between the
laboratories of E.C. Achberger, and R.J. Siebeling (Jenson, M.A.B., 1992). This work falls under
the umbrella of such collaboration (Diaz, M.A., et al, in press).
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In July of 1999, 11 of 16 turtle farms in Pierre Part had shipment lots fail certification.
Bacterial isolates were obtained for further studies from failed-lot turtle samples provided by the
Central Analytical Laboratories, Belle Chase, LA. Identification by standard bacteriological
assays and by API-20E (bioMérieux SA, Marcy l'Etoile, France) confirmed the presence of S.
enterica subsp. arizonae. All isolates tested were resistant to concentrations of gentamicin >2000
µg/ml, which is higher than the concentration used to treat the eggs. Other bacteria, such as
Enterobacter cloacae, Citrobacter freundii, Stenotrophomonas maltophilia and Pseudomonas
aeruginosa, among others, were also found to have this level of gentamicin resistance. We
became interested in studying the high-level gentamicin resistance expressed by these bacteria
since this resistance had not been reported in Gram-negative bacteria (Diaz, M.A., et al, 2000).
1.2 Aminoglycoside Antibiotics
Antibiotics are biochemical compounds produced by microorganisms which can inhibit the
growth or kill other microorganisms (Levy, S.B., 1998). They act selectively on prokaryotic
targets, which can be the bacterial cell wall, cell membrane function, nucleic acid synthesis,
protein synthesis or other bacterial enzymatic pathways (Levy, S.B., 1998; Mazel, D. and
Davies, J., 1999). Aminoglycoside antibiotics act by inhibiting prokaryotic protein synthesis
(Davis, B.D., 1987; Wright, G.D., et al, 1998; Azucena, E. and Mobashery, S., 2001; Vakulenko,
S.B. and Mobashery, S., 2003).
Aminoglycosides are produced by the Actinomycetes Streptomyces spp. (i.e. neomycin,
kanamycin and tobramycin) and Micromonospora spp. (i.e. gentamicin and sisomicin).
Gentamicin is produced by Micromonospora purpurea. There are also semisynthetic members of
the family, which are created by chemical modification of the original molecules, i.e. amikacin
and netilmicin (Davis, B.D., 1987; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery,
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S., 2003). The first aminoglycoside, streptomycin, was discovered in 1944 by Waksman, from
Streptomyces griseus (Waksman, S.A., 1958; Comroe, J.H., Jr., 1978).
Aminoglycosides consist of an aminocyclitol ring, 2-deoxystreptamine, or streptidine in
the case of streptomycin, which is joined by glycosidic bonds to two or more aminosugars
(Wright, G.D., et al, 1998). They are highly polar molecules of a relatively large size. The two
major classes of 2-deoxystreptamine aminoglycosides are the 4,5-disubstituted neomycin,
paramomycin, and ribostamycin, and the 4,6-disubstituted gentamicins and kanamycins.
Gentamicin, as well as kanamycin and amikacin, belong to the 4,6-disubstituted class of the 2deoxystreptamine aminoglycosides (Figure 1.2) (Davis, B.D., 1987; Wright, G.D., et al, 1998;
Vakulenko, S.B. and Mobashery, S., 2003).
1.2.1. Clinical Use
Aminoglycosides are highly-potent, broad-spectrum, bactericidal antibiotics that can be
used both on Gram-positive and Gram-negative bacteria (Moore, R.D., et al, 1987; Vakulenko,
S.B. and Mobashery, S., 2003). Gram-negative aerobic bacilli are particularly sensitive to these
antibiotics, and they are often the treatment of choice for infections from Gram-negative bacteria
such as Escherichia coli, Salmonella spp., Shigella spp., Enterobacter spp., Citrobacter spp.,
Acinetobacter spp., Proteus spp., Klebsiella spp., Serratia spp., Morganella spp., and
Pseudomonas spp (Vakulenko, S.B. and Mobashery, S., 2003). They are also used, generally in
combination therapy with cell wall active agents, to treat infections caused by Gram-positive
organisms such as Staphylococcus aureus and some streptococci (Vakulenko, S.B. and
Mobashery, S., 2003), as well as infections due to intracellular bacteria (Maurin, M. and Raoult,
D., 2001).
Aminoglycosides are relatively toxic to the eukaryotic host cell. Their therapeutic
window is rather small, which means there's a small difference between the serum concentration
6

needed for bactericidal action and the concentration of the drug that is toxic to the host (Moore,
R.D., et al, 1987; Wright, G.D., et al, 1998). At therapeutical concentrations, aminoglycosides
may also affect eukaryotic cells by nonspecific binding to eukaryotic ribosomes. Their use can
cause kidney and hearing damage, since these antibiotics can concentrate in these organs
(Bennett, W.M., et al, 1982; Brion, N., et al, 1984). In spite of the resistance problems

Figure 1.2. Chemical Structure of Gentamicin

that have arisen since the early 1970’s and their relatively high toxicity on the host, they are still
antibiotics of choice clinically, especially in combined therapeutic use with cell wall active βlactam antibiotics (Kotra, L.P., et al, 2000; Vakulenko, S.B. and Mobashery, S., 2003).
1.2.2. Mode of Action
Aminoglycosides act by inhibiting prokaryotic protein synthesis (Davis, B.D., 1987;
Azucena, E. and Mobashery, S., 2001). In order to take effect, they must first reach their target,
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the bacterial ribosome (Davis, B.D., 1987; Fourmy, D., et al, 1996). For this, they must penetrate
the cell wall and membranes. Penetration of the antibiotic into the bacterial cell is an important
step of their mode of action. It is an energy-dependent, rate-limiting step (Taber, H.W., et al,
1987; Yoshizawa, S., et al, 1998). The passage of these highly polar molecules through the
bacterial outer membrane is considered to be a self-promoted process that involves the disruption
of lipopolisaccharide molecules by the drug, a mechanism that is presently not fully understood
(Martin, N.L. and Beveridge, T.J., 1986; Kadurugamuwa, J.L., et al, 1993a; Kadurugamuwa,
J.L., et al, 1993b; Yoshizawa, S., et al, 1998). Transport through the cell membrane is thought to
depend on the electron transport machinery of the cell (Damper, P.D. and Epstein, W., 1981;
Wright, G.D., et al, 1998; Kotra, L.P., et al, 2000) and is inhibited by divalent cations, high
osmotic pressure, low pH and by anaerobiosis (Damper, P.D. and Epstein, W., 1981;
Schlessinger, D., 1988; Cavallero, A., et al, 1990).
Once inside the cell, aminoglycosides inhibit prokaryotic protein synthesis by binding to
the 30S ribosome subunit (Pfister, P., et al, 2003; Vakulenko, S.B. and Mobashery, S., 2003).
This binding doesn't affect the formation of the initiation complex of protein synthesis, but
rather, it interferes with the elongation of the nascent polypeptide. The process of proofreading is
thus compromised, resulting in misreading of the genetic code or premature termination of the
nascent chain (Konno, T., et al, 2004). This leads to a significant number of altered proteins.
When inserted in the cell membrane, these abnormal proteins alter the membrane permeability,
which allows an increased entry of the antibiotic into the cell. This step, in which more and more
of the drug is able to enter the cell and bind to the ribosomal target, leads irreversibly to cell
death. (Davis, B.D., 1987; Kotra, L.P., et al, 2000; Pfister, P., et al, 2003; Vakulenko, S.B. and
Mobashery, S., 2003; Konno, T., et al, 2004).
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1.2.3. The Ribosomal Target
Aminoglycoside antibiotics induce misreading of the genetic code by specifically binding
to the 16S ribosomal RNA A-site in bacteria (Fourmy, D., et al, 1996; Pfister, P., et al, 2003). In
particular, the 2-deoxystreptamine molecule binds to the 16S rRNA, close to the A-site tRNA
(Moazed, D. and Noller, H.F., 1987; Fourmy, D., et al, 1996). This site in the 16S rRNA to
which aminoglycosides bind is highly conserved in bacteria, archae and eukaryotes (Moazed, D.
and Noller, H.F., 1987; Ban, N., et al, 2000; Carter, A.P., et al, 2001). The 4,6 disubstituted 2deoxystreptamine aminoglycoside molecules have common chemical groups which are involved
in making sequence–specific contacts with the particular conserved nucleotides of the 16S rRNA
(Moazed, D. and Noller, H.F., 1987; Carter, A.P., et al, 2000).
The specificity and nature of aminoglycoside-ribosome contacts have been determined in
detail with A-site mutants displaying various levels of resistance and with structural studies of
the drug-target interaction (Moazed, D. and Noller, H.F., 1987; Pfister, P., et al, 2003). In this
regard, A-site mutants displaying resistance to aminoglycoside antibiotics have been useful to
determine the site of action of aminoglycoside antibiotics (Pfister, P., et al, 2003). Two critical
regions have been identified for the binding of aminoglycosides at the A-site of the ribosome;
these are an adenine residue at position 1408 (E. coli numbering) and the positioning of the
U1406 and U1495 bases (Pfister, P., et al, 2003). Furthermore, the effects of particular A-site
mutations vary according to the chemical characteristics of the drug molecule. For example, an A
to G mutation in position 1408 impairs the insertion of 6'-NH3+ aminoglycosides inside the Asite helix, which makes these mutants display high-level resistance to these drugs (Pfister, P., et
al, 2003). Moreover, chemical footprinting of A-site point mutants which display higher levels of
resistance have also stressed the importance of this site in the binding and action of
aminoglycosides (Carter, A.P., et al, 2000; Recht, M.I. and Puglisi, J.D., 2001).
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The elucidation of the crystal structure of aminoglycoside antibiotics bound to the A-site
of E. coli 16S ribosomal RNA has been useful in understanding the interaction of these drugs to
their target site (Fourmy, D., et al, 1996; Carter, A.P., et al, 2000; Pfister, P., et al, 2003).
Structural studies done with aminoglycosides such as paromomycin, tobramycin, and geneticin,
bound to oligonucleotides which contain a minimal A-site have indicated a key role of position
1406 of the 16S rRNA, particularly in the binding of ring III of the aminoglycoside molecule
(Moazed, D. and Noller, H.F., 1987; Fourmy, D., et al, 1996; Fourmy, D., et al, 1998a; Fourmy,
D., et al, 1998b; Carter, A.P., et al, 2000; Pfister, P., et al, 2003). Thus, alterations of the binding
sites of the ribosome or the aminoglycoside molecule that reduce the binding affinity of the drug
to the ribosome lead to varied levels of resistance, according to the nature of these changes
(Llano-Sotelo, B., et al, 2002; Pfister, P., et al, 2003; Vakulenko, S.B. and Mobashery, S., 2003).
1.3 Resistance to Aminoglycosides
Organisms can be intrinsically resistant to an antimicrobial or become resistant through
mutations or by the acquisition of new genes (Levy, S.B., 1998; Mazel, D. and Davies, J., 1999;
Rowe-Magnus, D.A. and Mazel, D., 1999). Bacteria can acquire resistance from an outside
source through conjugation, transformation, and transduction (Mazel, D. and Davies, J., 1999).
These mechanisms of genetic exchange allow bacteria to obtain favorable genes from other
bacteria (Davies, J. and Smith, D.I., 1978; Levy, S.B., 1998). Other modes of horizontal gene
transfer such as transposition, Gram-positive conjugative transposons, and the recently described
conjugative transposons in Gram-negative organisms, as well as the integrons of some Gramnegative bacteria, allow bacteria to acquire new genes through intermolecular genetic exchange
(Davies, J. and Smith, D.I., 1978; Stokes, H.W., et al, 2001; Pembroke, J.T., et al, 2002;
Carattoli, A., 2003; Partridge, S.R. and Hall, R.M., 2003). These mobile DNA elements have
played an important role in the evolution of microorganisms (Recchia, G.D. and Hall, R.M.,
10

1997; Simjee, S. and Gill, M.J., 1997; Hall, R.M., et al, 1999; Tolmasky, M.E., 2000; Pembroke,
J.T., et al, 2002; Rowe-Magnus, A.D., et al, 2002).
Microorganisms can become resistant to antibiotics through a variety of mechanisms,
which include the alteration of the drug’s target, reduced uptake or accumulation of the drug, and
the enzymatic modification of the antibiotic (Davis, B.D., 1987; Levy, S.B., 1998; Mazel, D. and
Davies, J., 1999).
1.3.1. Altered Target
There are two main modes through which bacteria can become resistant to
aminoglycosides by modifications of the ribosome: 1) through mutations in ribosomal proteins or
the rRNA, and 2) by enzymatic modification of the ribosome (Davis, B.D., 1987; Wright, G.D.,
et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003).
1.3.1.1. Target-Site Mutations
As mentioned above, any mutation that affects the binding sites of the ribosome can
reduce the binding affinity of the drug to the ribosome and lead to varied levels of resistance.
The effects of such mutations depend on the nature of the mutation and on the chemistry of the
drug (Fourmy, D., et al, 1996; Carter, A.P., et al, 2000; Llano-Sotelo, B., et al, 2002). For
example, mutations that inhibit the binding of ring I of aminoglycosides confer high-level
resistance to these drugs (Carter, A.P., et al, 2000; Recht, M.I. and Puglisi, J.D., 2001).
Mutations U1406-to-A confer higher levels of resistance as well as a partial dominance of
resistance to all 4,6 disubstituted 2-deoxystrepatamine aminoglycosides, by reducing the affinity
of the antibiotic for the rRNA target (Recht, M.I. and Puglisi, J.D., 2001; Pfister, P., et al, 2003).
Mutational changes in the 16S rRNA, or on ribosomal proteins, have been reported to
produce resistance mainly to streptomycin (Fernandez, R.O. and Anton, D.N., 1987; Melancon,
P., et al, 1988). These mutations are of clinical importance, particularly in Mycobacterium
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tuberculosis, since streptomycin is one of the drugs used for the treatment of tuberculosis
(Gillespie, S.H., 2002; Vakulenko, S.B. and Mobashery, S., 2003).
1.3.1.2. Enzymatic Modification of the Target Site
The other mode of target site alteration leading to aminoglycoside resistance is through
the enzymatic modification of the ribosome (Davis, B.D., 1987; Cundliffe, E., 1989; Wright,
G.D., et al, 1998). It is not uncommon to find modifications of the ribosome in microorganisms
producing antibiotics that target the ribosome, as a way of protecting themselves from the
antibiotics they produce (Cundliffe, E., 1989; Yoshizawa, S., et al, 1998). An example of this
can be found in some aminoglycoside-producing microorganisms where methylation of certain
guanine residues of the 16S rRNA produce high-level resistance to aminoglycoside antibiotics
(Cundliffe, E., 1989; Vakulenko, S.B. and Mobashery, S., 2003). Ribosomal modification has
been well documented in the gentamicin producer Micromonospora purpurea, as well as other
aminoglycoside-producers, such as Streptomyces tenjimariensis and Streptomyces tenebrarius
(Piendl, W. and Bock, A., 1982; Piendl, W., et al, 1984; Cundliffe, E., 1989).
For years, several studies strived to identify the genes that confer high-levels of resistance
in organisms that produce aminoglycosides (Cundliffe, E., 1989; Kojic, M., et al, 1992). Some of
this research has focused on methylase enzymes which confer aminoglycoside resistance to
aminoglycoside producing organisms (Thompson, J., et al, 1985). In one of these studies, J.
Thompson et al (1985) cloned fragments from the gentamicin producer, Micromonospora
purpurea into naïve E. coli cells and obtained a strain which was highly resistant to both
gentamicin and to kanamycin. The cloned methylase activity acted on the 16S RNA 30S
ribosomal subunits of E. coli, to produce the mentioned resistance phenotype. Later, in 1987, A.
A. Beauclerk and E. Cundliffe observed the sites of action of Micromonospora purpurea’s rRNA
methylases and determined that these enzymes made this aminoglycoside-producer resistant to
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high levels of gentamicin by the conversion of residue G-1405 to 7-methylguanosine within the
bacterial 16S ribosomal RNA (Beauclerk, A.A. and Cundliffe, E., 1987). The nature of such
interactions has also been studied in detail, based on sequence analysis as well as structural
studies (Carter, A.P., et al, 2000; Bujnicki, J.M. and Rychlewski, L., 2002).
Another group of researchers studied the aminoglycoside-resistance determinants that
they cloned from Micromonospora purpurea and the sisomicin producer Micromonospora rosea
(Kelemen, G.H., et al, 1991). They found that these resistance determinants showed a high
degree of identity between them, both at the structural and the functional level. Their studies
allowed them to identify the grm gene, which encodes a ribosomal RNA methyltransferase.
Furthermore, M. Kojic and collaborators (Kojic, M., et al, 1992) cloned a sisomicin-gentamicin
resistance methylase gene (sgm) from Micromonospora zionensis and found that its deduced
amino acid sequence also showed similarity to Grm enzymes, as well as to the 16S rRNA
methylase, KgmB.
The studies mentioned above show the effects that methylation of the ribosome can have
on aminoglycoside efficiency. The importance of the background of the aminoglycoside
producer strain for the effective action of gentamicin-resistance determinants has also been
investigated (Kojic, M., et al, 1999). Consequently, Micromonospora spp. strains that produce
aminoglycosides have been shown to express high-levels of resistance to their own products as
well as to antibiotics that are structurally similar, that is, those with a 4,6-disubstituted
deoxystreptamine aminocyclitol component (neomycin, kanamycin, or gentamicin). On the other
hand, these strains also proved to be sensitive to aminoglycoside antibiotics in which the
aminocyclitol ring had different types of substitutions, such as neomycin and apramycin (Kojic,
M., et al, 1999). These studies, which illustrate the importance of the aminoglycoside producer
background for the action of a particular resistance determinant, provide clues to the impact on
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the phenotype that ribosomal modification for self-protection has in antibiotic producers (Kojic,
M., et al, 1999).
Aminoglycoside resistance by enzymatic modification of the ribosome has recently
become an important focus of study due to the discovery of enzymes that modify the 16SrRNA
in bacteria other than antibiotic producers (Galimand, M., et al, 2003; Yokoyama, K., et al,
2003; Doi, Y., et al, 2004; Yamane, K., et al, 2004). This mode of aminoglycoside resistance by
modifications of the target involving enzymatic methylation of the rRNA in non-antibiotic
producers will be explained in a later section.
1.3.2. Adaptive Resistance
Adaptive resistance to aminoglycosides, which is a transient, reduced susceptibility to the
drug, has been reported mainly in aerobic Gram-negative bacilli (Davis, B.D., 1987; Wright,
G.D., et al, 1998). An example of these studies is one performed by Karlowski et al,1996, where
these researchers observed that stepwise increases in aminoglycoside concentrations allowed
Pseudomonas aeruginosa to grow in concentrations of aminoglycosides that would normally kill
the parent strains. However, adaptive changes are typically unstable, and are due to regulatory
events rather than mutations or the acquisition of resistance genes, so they don’t persist once the
selective pressure is removed (Karlowsky, J.A., et al, 1996). It is argued that such reduced
susceptibility could be due to protein changes or alteration in regulation genes of the respiratory
pathway, but the actual mechanism is poorly understood (Bryan, L.E. and Van Den Elzen, H.M.,
1977; Karlowsky, J.A., et al, 1996).
1.3.3. Drug Impermeability: Reduced Uptake and Active Efflux of Antibiotics
In order to take effect, aminoglycosides must first penetrate the cell wall and membranes,
and reach the bacterial ribosome (Bryan, L.E. and Van Den Elzen, H.M., 1977; Martin, N.L. and
Beveridge, T.J., 1986; Davis, B.D., 1987). Some microorganisms have developed ways to inhibit
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this important step of these drugs’ mode of action. Aminoglycoside resistance due to reduced
uptake of the drug is mainly seen in the pseudomonads and other non-fermentor Gram-negative
bacilli (Bryan, L.E. and Van Den Elzen, H.M., 1977; Martin, N.L. and Beveridge, T.J., 1986).
The mechanism of action of reduced drug uptake is generally due to membrane
impermeabilization, which impairs the drug penetration into the cell (Bryan, L.E. and Van Den
Elzen, H.M., 1977; Davis, B.D., 1987). This mode of resistance is clinically important since it is
stable and it results in an intermediate susceptibility to all of the aminoglycosides (Miller, G.H.,
et al, 1997; Lister, P.D., 2002). The precise molecular mechanisms that produce the
aminoglycoside impermeability type of resistance are yet unknown (Damper, P.D. and Epstein,
W., 1981; Davis, B.D., 1987; Schlessinger, D., 1988).
Another mechanism bacteria use to reduce the accumulation of an antibiotic within the
cell is through the active efflux, or pumping, of the drug out of the cell (Zgurskaya, H.I. and
Nikaido, H., 2000). This mechanism is more frequently observed in non-fermentor Gramnegative bacilli (Martin, N.L. and Beveridge, T.J., 1986; Westbrock-Wadman, S., et al, 1999),
but has been reported in other microorganims as well, including Samonella spp. and E. coli
(Nikaido, H., et al, 1998; Rosenberg, E.Y., et al, 2000). Multidrug efflux pumps generally have
low substrate specificity (Zgurskaya, H.I. and Nikaido, H., 2000). Furthermore, the presence of
different efflux pumps may confer additive or multiplicative effects on drug resistance (Lee, A.,
et al, 2000). Multidrug efflux pumps confer Gram-negative bacteria useful survival strategies,
which can follow the acquisition of foreign genes, as well as the activation or increased
expression of innate efflux systems (Westbrock-Wadman, S., et al, 1999; Putman, M., et al,
2000; Zgurskaya, H.I. and Nikaido, H., 2000; Lister, P.D., 2002).
Efflux pump systems have been classified in different families. ATP-dependent
multidrug transporters are those which use ATP as the energy source to drive the drug outside of
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the cell. Secondary multidrug transporters mediate the efflux of antibiotics from the cell in a
combined exchange with protons. The latter include 1) the major facilitator superfamily, 2) the
small multidrug resistance superfamily, 3) the multidrug and toxic compound extrusion
superfamily and 4) the resistance-nodulation-cell division family (Nikaido, H., et al, 1998;
Zgurskaya, H.I. and Nikaido, H., 2000; Mao, W., et al, 2001; Lister, P.D., 2002).
Pseudomonas aeruginosa, which is an important nosocomial pathogen that often presents
difficulties in therapy, is a non-fermentor Gram-negative bacillus which possesses intrinsic
resistance to multiple drugs (Lister, P.D., 2002). Over 90% of aminoglycoside-resistant P.
aeruginosa isolates from cystic fibrosis patients display the drug impermeability phenotype
(Westbrock-Wadman, S., et al, 1999; Lister, P.D., 2002), highlighting the importance of this
mechanism of resistance. P. aeruginosa’s natural resistance to aminoglycosides involves an
active efflux system, or pumps, as shown by aminoglycoside accumulation assays in mutants.
These involve energy-dependent systems that pump out aminoglycosides from the cell (Aires,
J.R., et al, 1999). Some examples of efflux pumps which confer resistance to aminoglycosides
include the MexXY-OprM efflux pump system found in P. aeruginosa (Mao, W., et al, 2001)
and the AcrD pump reported in E. coli (Rosenberg, E.Y., et al, 2000).
1.3.4. Enzymatic Modification of the Drug
The most important mechanism of aminoglycoside resistance is the enzymatic
modification of the antibiotic by Aminoglycoside Modifying Enzymes (AMEs), which results in
a molecule with decreased binding affinity to the target site at the ribosome (Wright, G.D., et al,
1998; Vakulenko, S.B. and Mobashery, S., 2003). This mode of resistance involves the presence
of genes that code for enzymes that modify these antibiotics. The family of AMEs is divided in
three main classes according to their enzymatic activity: 1) the aminoglycoside
phosphoryltransferases (APH) participate in the ATP-dependent phosphorylation of hydroxyl
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groups in the drug; 2) the aminoglycoside nucleotidyltransferases (ANT) catalyze the ATPdependent adenylation of certain hydroxyl groups; and 3) the aminoglycoside acetyltransferases
(AAC) participate in the acetylCoA-depedent acetylation of specific aminoglycoside amino
groups (Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Azucena, E. and Mobashery, S., 2001;
Vakulenko, S.B. and Mobashery, S., 2003). This last class of the AMEs constitutes the largest
group in the family and is the group relevant to this study (Shaw, K.J., et al, 1993; van de
Klundert, J.A. and Vliegenthart, J.S., 1993).
1.3.4.1. Nomenclature of Aminoglycoside Modifying Enzymes
AMEs display substrate specificity, which means that each enzyme will modify a specific
chemical group, resulting in a particular phenotype (Shaw, K.J., et al, 1993; Wright, G.D., et al,
1998). Due to the large number of AMEs that have been described to date, a uniform
nomenclature system was proposed by K.J. Shaw (Shaw, K.J., et al, 1993) to denominate these
enzymes and avoid confusion. Briefly, the first three letters of the name should refer to the
enzymatic action, followed by a number in parenthesis designating the group modified, then a
Roman numeral, indicating the resistance profile, and lastly, a lower case letter indicating the
individual gene or enzyme (Shaw, K.J., et al, 1993; van de Klundert, J.A. and Vliegenthart, J.S.,
1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Figure 1.3, Figure
1.4 and Figure 1.5 indicate the chemical groups of an aminoglycoside molecule modified by
different AMEs.
1.3.4.2. Aminoglycoside Acetyltransferases
Aminoglycoside acetyltransferases are the largest group in the family of the AMEs
(Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998). There are four classes of enzymes within this
group, according to the amino group that is acetylated in the aminoglycoside molecule. These are
AAC(1), AAC(3), AAC(2”), and AAC(6”) (Shaw, K.J., et al, 1993). These enzymes use the
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acetyl group from an acetyl coenzyme-A donor molecule to modify the aminoglycoside molecule
at the 1 and 3 positions of the 2-deoxystreptamine ring, and the 2” and 6” positions of the 6aminohexose ring, respectively (Shaw, K.J., et al, 1993; Vakulenko, S.B. and Mobashery, S.,
2003).
Several resistance patterns have been found within the class of AACs which modify the
aminoglycoside molecule at position 3 of the 2-deoxystreptamine ring, or AAC(3). One of the
resistance phenotypes of interest in this study corresponds to the AAC(3)-II resistance pattern
(Diaz, M.A., et al, 2000; Diaz, M.A., et al, 2001). The phenotype of these enzymes involves
resistance to gentamicin, tobramycin, sisomicin, netilmicin, and dibekacin (Shaw, K.J., et al,
1993; Miller, G.H., et al, 1997; Vakulenko, S.B. and Mobashery, S., 2003). Three different
aac(3)-II genes have been identified to date, which encode enzymes AAC(3)-IIa, -IIb, and -IIc.
Genes aac(3)-IIc and aac(3)-IIb have been reported to share 97% and 72% identity with the
aac(3)-IIa gene, respectively (Vakulenko, S.B. and Mobashery, S., 2003). These enzymes had
previously been named AAC(3)-III (Allmansberger, R., et al, 1985) and AAC(3)-V (Brau, B., et
al, 1984; Rather, P.N., et al, 1992) until later analysis revealed them to be identical to the
AAC(3)-II (Shaw, K.J., et al, 1993; Vakulenko, S.B. and Mobashery, S., 2003).
Clinically, AAC(3)-II enzymes are frequently found in Gram-negative bacteria, with a
frequency that varies from 18% to 60% relative to other phenotypes (Miller, G.H., et al, 1997;
Vakulenko, S.B. and Mobashery, S., 2003). The most frequent gene producing the AAC(3)-II
phenotype is AAC(3)-IIa, which accounts for 85% of the bacteria presenting this phenotype
(Miller, G.H., et al, 1997). This gene was originally identified in R-plasmids (Allmansberger, R.,
et al, 1985).
Three other AAC(3) resistance patterns, AAC(3)-III, AAC(3)-IV, and AAC(3)-VI, occur
rarely among clinical isolates, and patterns AAC(3)-VII, -VIII, -IX, and -X have been discovered
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Figure 1.3. Aminoglycoside Phosphotransferase Enzymes

Figure 1.4. Aminoglycoside Nucleotidyltransferase Enzymes

Figure 1.5. Aminoglycoside Acetyltransferase Enzymes
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in aminoglycoside- producing actinomycetes (Vakulenko, S.B. and Mobashery, S., 2003). The
phenotype of AAC(3)-VI, of interest in this investigation, includes resistance to gentamicin
(Shaw, K.J., et al, 1993; Miller, G.H., et al, 1997; Diaz, M.A., et al, 2000; Diaz, M.A., et al,
2001; Vakulenko, S.B. and Mobashery, S., 2003). The gene aac(3)VI was originally cloned from
a conjugative plasmid of Enterobacter cloacae. It reportedly shares 50% amino acid identity
with the deduced amino acid sequence from the aac(3)-IIa gene (Rather, P.N., et al, 1993;
Vakulenko, S.B. and Mobashery, S., 2003).
1.4 High-Level Gentamicin Resistance (HLGR)
1.4.1. HLGR in Gram-Positive Organisms
The majority of aminoglycoside modifying enzymes present enough activities to result in
effective resistance to aminoglycosides, but only certain phosphotransferase enzymes have been
reported to produce high-levels of resistance to these antibiotics (Galimand, M., et al, 2003;
Vakulenko, S.B. and Mobashery, S., 2003). To the best of our knowledge, there had been no
reports in the literature of high-level resistance to gentamicin in Gram-negative bacteria before
the start of this study in 1999 (Diaz, M.A., et al, 2000). There had been numerous reports on
high-level gentamicin resistance in Gram-positive bacteria (Chow, J.W., 2000). Reports on the
variety of structures involved in the transfer of these determinants in Gram-positive bacteria
were also abundant (Ferretti, J.J., et al, 1986; Chow, J.W., 2000).
The enzyme AAC(6’)-APH(2”) was the first to be reported to cause the high-level
gentamicin resistance phenotype (Shaw, K.J., et al, 1993; Chow, J.W., 2000). It confers highlevel gentamicin resistance to Gram-positive organisms due to its 6'-N-acetyltransferase and 2"O-phosphotransferase activities (Shaw, K.J., et al, 1993). The combined acetylation and
phosphorylation of specific amino and hydroxyl groups by this enzyme gives it a broad substrate
specificity in both enzymatic activities (Wright, G.D., et al, 1998; Kotra, L.P., et al, 2000). This
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enzyme makes aminoglycoside therapy inefficient for the treatment of pathogenic enterococci
and staphylococci (Daigle, D.M., et al, 1999; Chow, J.W., 2000).
High-level aminoglycoside resistance in enterococci is generally mediated by these
aminoglycoside-modifying enzymes (Fluit, A.C., et al, 2003). This level of resistance eliminates
the synergistic bactericidal effect that is normally obtained by the combined use of cell wallactive agents, such as β-lactams, with aminoglycosides (Chow, J.W., 2000), which is clinically
relevant since this is often a treatment of choice for infections caused by these microorganisms
(Miller, G.H., et al, 1997; Vakulenko, S.B. and Mobashery, S., 2003).
High-level gentamicin resistance, often refered to as HLGR, is found in almost all
enterococcal species involved in human infection (Straut, M., et al, 1996; Chow, J.W., 2000;
Fluit, A.C., et al, 2003). In fact, the majority of Enterococcus spp. tested to date have been
shown to encode genes with homology to the gene aac(6’)-aph(2”), also found in the literature
as the aac6-aph2 gene (Ferretti, J.J., et al, 1986).
The gene coding this bifunctional enzyme has been reported to be carried either by
Tn4001-like structures or by Tn4001-truncated elements (Ferretti, J.J., et al, 1986) and to present
insertion sequences IS256 and IS257 in its molecular environment. It has been detected in other
HLGR strains of Gram-positive bacteria, such as Staphylococcus aureus, Streptococcus spp.,
Ent. faecalis and Ent. faecium (Ferretti, J.J., et al, 1986), and in the chromosome of
Streptococcus mitis (Kaufhold, A. and Potgieter, E., 1993). Plasmid-borne gene aac(6’)-aph(2”)
has also been detected in other enterococcal species displaying HLGR, namely Ent. hirae, Ent.
avium, and Ent. raffinosus (Sahm, D.F. and Gilmore, M.S., 1994; Straut, M., et al, 1996;
Shiojima, M., et al, 1997). The genes encoding this bifunctional enzyme have been shown to be
highly homologous in Enterococcus faecalis, Enterococcus faecium, and Streptococcus
agalactiae (Ounissi, H., et al, 1990; Kaufhold, A., et al, 1992).
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Recently, other genes have been reported to account for plasmid-encoded high-level
gentamicin resistance in Enterococcus faecium (Chow, J.W., 2000; Vakulenko, S.B. and
Mobashery, S., 2003). In 1998, S.F. Tsai et al identified a new high-level gentamicin resistance
gene, aph(2'')-Id, in Enterococcus spp. (Tsai, S.F., et al, 1998). The deduced amino acid
sequence for this gene has a region which presents homology to the aminoglycoside-modifying
enzyme APH(2'')-Ic, which reportedly confers mid-levels resistance to gentamicin (Chow, J.W.,
et al, 1997); it also presents homology to the C-terminal domain of the bifunctional enzyme
AAC(6')-APH(2'') (Chow, J.W., et al, 1997; Chow, J.W., et al, 2001; Vakulenko, S.B. and
Mobashery, S., 2003). Later, in 2000, S.J. Kao et al cloned a new high-level gentamicin
resistance gene, aph(2")-Ib, from Enterococcus faecium strain SF11770, with homology to the
enzymes AAC(6’)-APH(2”), APH(2")-Ic, and APH(2")-Id (Kao, S.J., et al, 2000). Interestingly,
gene aph(2”)-Ib was recently detected in E. coli as well as in Enterococcus faecium, findings
that suggest a horizontal transfer of these genes between Gram-positive and Gram-negative
bacteria (Chow, J.W., et al, 2001). In conclusion, recently reported genes accounting for
plasmid-encoded high-level gentamicin resistance in Enterococcus faecium include: aph(2”)-Ib
and aph(2”)-Id (Tsai, S.F., et al, 1998; Chow, J.W., 2000; Kao, S.J., et al, 2000). It is relevant to
mention that even though aph(2”)-Ib has been reported in Gram-negative bacteria, there are no
reports to date of any aminoglycoside modifying enzyme causing the HLGR phenotype in these
bacteria (Galimand, M., et al, 2003; Yamane, K., et al, 2005).
1.4.2. Transfer of Gentamicin Resistance Genes in Gram-Positive Organisms
Various reports in Europe, the United States, and other places in the world have
ascertained that HLGR is an important cause of nosocomial enterococcal infections (Murray,
B.E., 1990; Fluit, A.C., et al, 2003). This may in part be due to the fact that HLGR determinants
are present on mobile molecular elements which can facilitate their spread among Gram-positive
22

organisms (Ferretti, J.J., et al, 1986; Tolmasky, M.E., 2000; Fluit, A.C., et al, 2003). In this
sense, several reports have revealed an ample variety of structures associated with the genetic
variability and transfer of gentamicin resistance in Gram-positive organisms. For example, some
studies have described the plasmid contents in clinical isolates of HLGR Enterococcus faecalis
as highly heterogenous (Zervos, M.J., et al, 1986; Casetta, A., et al, 1998; Daikos, G.L., et al,
2003). These have found the gentamicin resistance determinants either on conjugative, or on
nonconjugative, mobilizable plasmids. In addition, the bi-functional enzyme AAC(6’)-APH(2”)
has been found to be encoded on both narrow and broad host range plasmids (Simjee, S. and
Gill, M.J., 1997), as well as on conjugative transposons (Sahm, D.F. and Gilmore, M.S., 1994;
Casetta, A., et al, 1998; Murray, B.E., 1998; Culebras, E. and Martinez, J.L., 1999; Simjee, S., et
al, 1999).
Overall, studies on gentamicin resistance in enterococci report isolating plasmids from
transconjugants with sizes ranging from 45 kb to larger than 80 kb. All these plasmids are
reported to carry the gene aac(6’)-aph(2”) for HLGR. Nevertheless, the molecular environment
or flanking regions of this gene is reported to vary significantly (Sahm, D.F. and Gilmore, M.S.,
1994; Horvat, R.T., et al, 1998; Simjee, S., et al, 1999). As an example of this variability, one
study reported this gene to be found as a Tn4001-like alpha element on the Ent. faecalis
chromosome, as well as a Tn4001-truncated type I structure on a conjugative plasmid, and even
on both (Casetta, A., et al, 1998). The heterogeneity observed in plasmid contents and in the
molecular environments of this gene in clonally related enterococci argues against a clonal
dissemination of gentamicin resistant strains (Culebras, E. and Martinez, J.L., 1999).
Studies done on Ent. faecalis have further characterized the plasmids carrying the HLGR
determinants as pheromone-responsive conjugative plasmids (Shiojima, M., et al, 1997; Murray,
B.E., 1998). These pheromone-responsive plasmids are characterized by giving a mating
23

response to small sex pheromones secreted by potential recipient cells. This event is involved in
the formation of mating aggregates and plasmid transfer (Salyers, A.A., et al, 1995; Shiojima,
M., et al, 1997; Tolmasky, M.E., 2000). Until recently, conjugative transposons had only been
reported in Gram-positive bacteria (Salyers, A.A., et al, 1995). However, recent studies
(Pembroke, J.T., et al, 2002) have described the presence of similar though unrelated structures
in Gram-negative bacteria. This subject has become a hot topic since and will be discussed in a
later section.
HLGR genes can also be transferred among different genera of Gram-positive organisms
(Sahm, D.F. and Gilmore, M.S., 1994). One example of this is a study which identifies the same
antimicrobial resistance genes in enterococci and staphylococci on the enterococcal transposon
Tn5384. The study supports the evolution of a composite transposon through cointegration of
enterococcal and staphylococcal plasmids, though this genetic transfer between enterococci and
staphylococci is still not well defined nor understood. Additionally, the molecular structures
mentioned so far also play a key role in the dissemination of resistant strains between different
regions of the world (Fluit, A.C., et al, 2003; Hallgren, A., et al, 2003). This dissemination is
illustrated by a study in the UK (Simjee, S., et al, 1999) that detected a Tn5281-like element
carrying the aac(6’)-aph(2”) gene (with and without an associated 70 kb plasmid) in clinical
isolates of Enterococcus faecium, which had been originally detected in a Enterococcus faecalis
strain HH22 from the USA (Daigle, D.M., et al, 1999; Simjee, S., et al, 1999).
In general, studies conducted on the origin and spread of the aac(6’)-aph(2”) gene
suggest that the origin of this gene is not clonal, but it is rather due to the combination of events
such as plasmid conjugation, together with multiple insertion events, which have facilitated the
rapid spread of this aminoglycoside resistance gene among Gram-positive bacteria (Simjee, S.
and Gill, M.J., 1997; Culebras, E. and Martinez, J.L., 1999).
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1.5 Integrons
1.5.1. Definition and Classes
Integrons are gene-capture molecular elements that contain an integrase gene, named intI,
and an arrangement of gene cassettes which are expressed from a common promoter (Stokes,
H.W. and Hall, R.M., 1989; Collis, C.M. and Hall, R.M., 1995). They were first described by
H.W. Stokes and R.M. Hall (Stokes, H.W. and Hall, R.M., 1989) and since then, the literature
abounds with reports of these molecular elements, which are often found on the plasmids and/or
the chromosomes of Gram-negative bacteria (Hall, R.M. and Stokes, H.W., 1993; Recchia, G.D.
and Hall, R.M., 1997; Fluit, A.C. and Schmitz, F.J., 1999; Hall, R.M., et al, 1999; RoweMagnus, D.A. and Mazel, D., 1999).
Gene cassettes are defined as small mobile elements generally composed of a single gene,
plus a site known as the 59-base element (59be) or attC (Stokes, H.W. and Hall, R.M., 1989;
Hall, R.M. and Collis, C.M., 1995). Gene cassettes can be inserted or excised from the integron
through site-specific recombination, an event that is catalized by the integrase IntI (Stokes, H.W.
and Hall, R.M., 1989; Collis, C.M. and Hall, R.M., 1992b; Hall, R.M. and Collis, C.M., 1995;
Stokes, H.W., et al, 1997; Collis, C.M., et al, 2001).
The majority of gene cassettes described to date code for antibiotic resistance (Fluit, A.C.
and Schmitz, F.J., 1999; Fluit, A.C. and Schmitz, F.J., 2004). Integrons which encode these
resistance genes are known as Multiple Resistance Integrons or MRIs. More than 70 different
antibiotic resistance gene cassettes have been reported in the MRIs to date, and they include
resistance genes to most of the existing antibiotic families (Recchia, G.D. and Hall, R.M., 1995;
Fluit, A.C. and Schmitz, F.J., 1999; Mazel, D. and Davies, J., 1999).
Integrons are divided into different classes, according to the IntI integrase and the general
gene arrangement that they encode. Before 2001, only four classes of integrons had been
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identified, mainly from clinical isolates. These were integrons class-1 (Stokes, H.W. and Hall,
R.M., 1989), class-2, class-3 (Collis, C.M., et al, 2002a) and class-4 (Mazel, D., et al, 1998).
Class-4 integrons are what is now called the Vibrio cholerae Super Integron (Mazel, D.,
et al, 1998; Clark, C.A., et al, 2000). This larger type of integron, referred to as “superintegrons” or SIs and originally described in Vibrio cholerae (Mazel, D., et al, 1998; RoweMagnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D., 1999; Clark, C.A., et al, 2000),
were later found as integral components of the genomes of other γ-proteobacteria, such as
Xanthomonas spp., Shewanella spp. and Pseudomonas spp. (Rowe-Magnus, D.A., et al, 1999;
Rowe-Magnus, D.A. and Mazel, D., 1999; Vaisvila, R., et al, 2001).
SIs are believed to have played an important role in bacterial gene exchange and
evolution (Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 2001; RoweMagnus, D.A., et al, 2002; Fluit, A.C. and Schmitz, F.J., 2004). Their gene cassettes can be
implicated in virulence or other functions different from drug resistance, as recently observed in
cassette-encoded genes with metabolic functions in the class-4 integron on the Vibrio cholerae
genome (Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 2001; RoweMagnus, D.A., et al, 2003). This finding advocates for a broader role for these bacterial elements
in adaptive bacterial evolution than originally considered (Rowe-Magnus, D.A., et al, 2001;
Rowe-Magnus, D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, F.J., 2004).
In addition to the four classes of integrons originally reported (Stokes, H.W. and Hall,
R.M., 1989; Mazel, D., et al, 1998; Collis, C.M., et al, 2002a), new integron classes have been
discovered in recent studies (Nield, B.S., et al, 2001; Stokes, H.W., et al, 2001). This Australian
group designed degenerate primers from conserved sequences in the genes coding for the known
integrases and used them to screen for new putative integrases in environmental samples. This
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same screening strategy proved helpful in a later study conducted to detect new gene cassettes
from the environment (Stokes, H.W., et al, 2001).
1.5.2. Class-1 Integrons: Structure
Class-1 integrons are the most prevalent integrons among clinical isolates (Hall, R.M.
and Stokes, H.W., 1993; Fluit, A.C. and Schmitz, F.J., 1999). They are characterized by the
presence of two conserved sequences, known as the 5’CS and 3’CS, which flank a variable
region (Figure 1.6) (Bennett, P.M., 1999). The 5'-conserved region contains the integrase gene
intI1 and a gene cassette attachment site, attI. The 3'-conserved region is characterized by the
presence of a sulfonamide resistance gene, sul1, a quaternary ammonium compound resistance
gene, qacE∆1, and open reading frames orf5 and orf6, with unknown functions. The variable
region of class-1 integrons can code for one or more gene cassettes (Stokes, H.W. and Hall,
R.M., 1989; Hall, R.M. and Stokes, H.W., 1993).
Gene cassettes are excised from integrons as covalently-closed circles (Collis, C.M. and
Hall, R.M., 1992b; Collis, C.M. and Hall, R.M., 1992a). They are generally inserted at a specific
site in the integron, known as the attI site (Collis, C.M. and Hall, R.M., 1992b; Collis, C.M., et
al, 1993; Stokes, H.W., et al, 1997). This site, together with the 59be site, are the substrates for
the site-specific recombinase IntI (Hall, R.M. and Collis, C.M., 1995; Collis, C.M., et al, 1998;
Collis, C.M., et al, 2001). The majority of gene cassettes are found integrated at the attI site of
integrons, but some gene cassettes have also been described on secondary sites, or 2°rs (Stokes,
H.W. and Hall, R.M., 1989; Recchia, G.D., et al, 1994; Hall, R.M. and Collis, C.M., 1995;
Recchia, G.D. and Hall, R.M., 1995; Collis, C.M., et al, 2001). IntI integrases bind preferentially
to the adjacent attI site for the recombination reaction with a 59be site (Collis, C.M., et al,
2002b).
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As mentioned above, gene cassettes possess a 59be which, together with the attI site,
serves as the substrate for the integron integrase (Collis, C.M., et al, 1993; Hall, R.M. and Collis,
C.M., 1995; Stokes, H.W., et al, 1997). The 59be or attC sites of different gene cassettes can
vary considerably in their length and in sequence. Thus, they can measure anywhere from 57 to
141 base pairs (Hall, R.M., et al, 1991; Collis, C.M., et al, 1993; Hall, R.M. and Collis, C.M.,
1995).

Figure 1.6. General Structure of a Class-1 Integron

59-base elements are unique for each gene cassette. There are regions at the ends of these
sites, measuring approximately 25 bp, which display a certain degree of similarity and which are
imperfect inverted repeats of each other (Hall, R.M., et al, 1991; Collis, C.M., et al, 1993; Hall,
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R.M. and Collis, C.M., 1995). Each of these sequences contain inversely oriented integrasebinding domains, which have the consensus sequences, RYYYAAC and G↓TTRRRY (Hall,
R.M., et al, 1991; Collis, C.M., et al, 1993; Hall, R.M. and Collis, C.M., 1995; Rowe-Magnus,
D.A., et al, 2001). They are known as the inverse core site (ICS) and the core site (CS) of gene
cassettes, respectively. They are separated by a spacer of 7 or 8 bp (Hall, R.M., et al, 1991;
Stokes, H.W., et al, 1997).
As opposed to attC sites, integron attI sites are not closely related to each other, and they
do not share the features described in the previous paragraphs for attC (Hall, R.M., et al, 1991;
Partridge, S.R., et al, 2000). The attI site only has one site structure, with two directly repeated
integrase-binding domains located at the left side (Collis, C.M. and Hall, R.M., 1995; Hall, R.M.
and Collis, C.M., 1995; Collis, C.M., et al, 2001).
As mentioned above, the sequences which flank gene cassettes can vary a great deal
between the different integron classes (Hall, R.M., et al, 1994; Stokes, H.W., et al, 1997; Stokes,
H.W., et al, 2001). However, identical cassettes have been found to be encoded in integrons of
different classes, which indicates that the gene cassette pool is probably shared between them
(Fluit, A.C. and Schmitz, F.J., 1999; Rowe-Magnus, D.A. and Mazel, D., 1999; Rowe-Magnus,
D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, F.J., 2004). The fact that gene cassettes may
possibly be exchanged between the different integron classes advocates that they may have
played an important role in bacterial evolution (Rowe-Magnus, D.A. and Mazel, D., 1999;
Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 2001; Rowe-Magnus,
D.A., et al, 2002). In effect, the flexibility that integrons confer to bacteria allows them to adapt
rapidly to unpredictable environmental challenges by allowing bacteria to acquire favorable
genes that can result in an improved fitness (Hall, R.M., et al, 1999; Rowe-Magnus, D.A. and
Mazel, D., 1999; Rowe-Magnus, D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, F.J., 2004).
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Likewise, any gene that proves to be useless may be eliminated via a similar mechanism (Hall,
R.M., et al, 1999; Fluit, A.C. and Schmitz, F.J., 2004). On the other hand, the majority of the
cassettes in the SIs are not expressed. Even so, they are believed to be maintained in the absence
of selective pressure as a genetic resource for the evolution of new genes (Rowe-Magnus, D.A.
and Mazel, D., 1999; Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D.,
2001; Rowe-Magnus, D.A., et al, 2002).
The origins of the gene cassettes are not known, yet it is suggested that cassettes from
multiple resistance integrons may be relatively ancient structures (Recchia, G.D. and Hall, R.M.,
1997). Moreover, it is suspected that MRIs evolved from super integrons through the recruitment
of super-integron gene cassettes (Rowe-Magnus, D.A., et al, 2002; Hall, R.M. and Stokes, H.W.,
2004). This is illustrative of how super-integrons have had an important impact on the bacterial
evolution of antibiotic resistance through the recruitment of super-integron gene cassettes
(Rowe-Magnus, D.A., et al, 2002; Hall, R.M. and Stokes, H.W., 2004).
1.5.3. Gene Expression
Integrons can be regarded as natural bacterial expression vectors (Collis, C.M. and Hall,
R.M., 1995; Hall, R.M. and Collis, C.M., 1995). There is a considerable degree of variability in
the level of expression of the genes encoded as gene cassettes. This variability of expression can
be accounted for by the intrinsic characteristics of both the gene cassettes and the integron
(Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995; Hall, R.M. and Collis, C.M., 1995;
Recchia, G.D. and Hall, R.M., 1995).
The expression of gene cassettes has been intensely studied at the transcriptional level
(Collis, C.M. and Hall, R.M., 1995; Hall, R.M. and Collis, C.M., 1995; Ploy, M.C., et al, 2000).
Gene cassettes are inserted in integrons in the same orientation with respect to their coding
sequence. Their initiation codons are located close to their 5’ end (Hall, R.M. and Collis, C.M.,
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1995). With a few exceptions, gene cassettes do not contain a promoter of their own. They are
instead expressed from a common promoter, Pant or P1, or rarely from another promoter, P2
(Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995; Stokes, H.W., et al, 2001). The P1
promoter sequence has strong sequence similarity to the Escherichia coli σ70 promoter consensus
sequence. Both P1 and P2 promoters are located in the 5’-conserved segment (5’-CS) of class 1
integrons. Pant is in a region in the 5’-CS called the 59-conserved segment, located at 59 bases
from the gene cassettes; it is 200 bp upstream from the cassette-encoded genes inserted at the
attI1 site (Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995).
Several factors can affect the expression of the gene cassettes in an integron (Ploy, M.C.,
et al, 2000). Multiple studies on the promoter sequences have confirmed that variations in the
sequence of Pant can affect the level of expression of a given gene by more than 20-fold
(Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995). Thus, mutations and natural
variants of Pant have been shown to have an effect on the expression of gene cassettes, as
measured by the level of antibiotic resistance conferred by the cassettes encoded downstream of
such promoters (Levesque, C., et al, 1994; Ploy, M.C., et al, 2000). Another factor that can
significantly affect the expression of gene cassettes is the order in which the cassette is inserted
in the integron. Thus, the level of resistance conferred is higher for the resistance genes that are
located in the first place, i.e. the first cassette. Likewise, it is reduced when there are preceding
cassettes (Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995; Ploy, M.C., et al, 2000).
In effect, when various cassette configurations are present, several RNA transcripts can be
detected, with different lengths. From the lenghth of the most abundant transcripts, it has become
evident that they terminate near the 59be end of individual cassettes, which suggests that the
59be may also act as transcription terminators (Levesque, C., et al, 1994; Collis, C.M. and Hall,
R.M., 1995).
31

1.6 Conjugative Transposons in Gram-Negative Bacteria
Conjugative transposons are DNA elements that can excise themselves to form a
covalently closed circular intermediate (Salyers, A.A., et al, 1995). Subsequently, this
intermediate can reintegrate itself within the same organism, or it can be transfered by
conjugation to a recipient cell and then integrate in the recipient’s genome (Salyers, A.A., et al,
1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, R.M., 2003). These integrative
molecular elements were first found in Gram-positive bacteria such as the streptococci and
enterococci (Tolmasky, M.E., 2000), and were barely mentioned before 1996 in connection with
Gram-negative bacteria (Pembroke, J.T., et al, 2002). Conjugative transposon-like elements were
later detected in Gram-negative bacteria, such as Bacteroides spp. (Salyers, A.A., et al, 1995;
Pembroke, J.T., et al, 2002), and though characterized to a lesser extent, in the
Enterobacteriaceae. Conjugative transposon-like elements have been reported in Salmonella
spp., Proteus spp., in the SXT element in Vibrio spp. and in the element known as R391
(Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, R.M., 2003).
Gram-negative conjugative transposons differ considerably from those of Gram-positive
organisms (Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall,
R.M., 2003). Some distinguishing features are that they generally are larger than Gram-positive
conjugative transposons and they carry genes which are derived from diverse sources. In fact,
they resemble what would be an intermediate between a phage and a plasmid, or “phagemid”.
However, this denomination has been avoided to prevent confusing them with the genetically
engineered elements (Pembroke, J.T., et al, 2002).
Gram-negative conjugative transposons have a broad host range, which gives them a key
role in the dissemination of antibiotic resistance genes among these bacteria (Salyers, A.A., et al,
1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, R.M., 2003). Many conjugative
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transposons are also able to mobilize plasmids, so the resitance genes do not need to be coded on
the conjugative transposon themselves in order to be transferred (Salyers, A.A., et al, 1995).
STX is a conjugative integrating element derived from Vibrio cholerae (Beaber, J.W., et
al, 2002b; Pembroke, J.T., et al, 2002). Genomic and functional research done on this integrating
antibiotic resistance gene transfer element has provided insight on the structure of conjugative
transposons. Another such structure, known as R391, has also provided a basis to define the
genetic structure of these resistance gene mobilization determinants (Beaber, J.W., et al, 2002a;
Pembroke, J.T., et al, 2002). Interestingly, conjugative transposons are thought to be related to
enteric pathogenicity islands in the Enterobacteriaceae (Pembroke, J.T., et al, 2002).
1.7 16S rRNA Methylases
As mentioned before, one of the modes of acquisition of aminoglycoside resistance
through alteration of the target site involves the enzymatic methylation of the 16S rRNA (Carter,
A.P., et al, 2000; Pfister, P., et al, 2003; Vakulenko, S.B. and Mobashery, S., 2003). This mode
of ribosomal protection, involving the production of 16S rRNA methylase enzymes, was
previously detected and reported only in aminoglycoside-producing actinomycetes (Thompson,
J., et al, 1985; Cundliffe, E., 1989). Recently, however, this mode of resistance has also been
reported in Gram-negative organisms such as Pseudomonas aeruginosa (Yokoyama, K., et al,
2003; Yamane, K., et al, 2004), Serratia marcescens (Doi, Y., et al, 2004), and, more relevant to
this study, members of the Enterobacteriaceae (Galimand, M., et al, 2003; Yamane, K., et al,
2005). This type of modification is clinically important, since it confers high-level resistance to a
broad range of aminoglycosides, whereas aminoglycoside-modifying enzymes are substratespecific, so they don’t confer resistance to different types of aminoglycosides (Shaw, K.J., et al,
1993; Miller, G.H., et al, 1997; Galimand, M., et al, 2003; Vakulenko, S.B. and Mobashery, S.,
2003).
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So far the discussion has centered on the mechanisms of Gram-positive organisms and
aminoglycoside producers to resist high-levels of these antibiotics. In effect, until recently there
had been no reports, to the best of our knowledge, of the acquisition of genes confering highlevels of resistance to aminoglycosides in Gram-negative organisms (Galimand, M., et al, 2003).
In the first stages of our studies, we had hypothesized that we would find a second gene which
could act in synergy with the already identified aac(3)IIa gene product to confer high-level
gentamicin resistance to several members of the Enterobacteriaceae isolated in our laboratories
and which displayed the HLGR phenotype (Diaz, M.A., et al, 2000).
Recently, however, a group of investigators from the Pasteur Institut in Paris, published a
study that has reoriented our research. In brief, M. Galimand (Galimand, M., et al, 2003) found
that the high-level aminoglycoside resistance in a clinical strain of Klebsiella pneumoniae was
due to both the presence of the aac3-II gene as well as to a new aminoglycoside resistance
methylase gene: armA. The enzyme encoded by the latter, ArmA, reportedly shares 37-47%
similarity with the 16S rRNA m(7)G methyltransferases from various actinomycetes (Galimand,
M., et al, 2003). In this study, these investigators demonstrated that methylation of 16S rRNA
can confer high-level resistance to a broad-range of aminoglycosides in Gram-negative
organisms, including the pathogen they studied. In addition, the same clinical strain of Klebsiella
pneumoniae also had genes blaTEM1, blaCTX-M, dfrA12, sul1 and ant(3")9, which conferred
resistance to beta-lactams, trimethroprim, sulfonamides and streptomycin-spectinomycin,
respectively. Interestingly, the gene armA has a low GC content, making it improbable that this
gene originated from aminoglycoside-producing actinomycetes (Galimand, M., et al, 2003).
Concurrently in Japan, a group of researchers (Yokoyama, K., et al, 2003) cloned and
reported an aminoglycoside-resistance gene, rmtA, from a clinical isolate of Pseudomonas
aeruginosa AR-2. The enzyme encoded by this gene, RmtA, confers high-level resistance to
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various aminoglycosides, with a MIC>1024 mg/L (Yokoyama, K., et al, 2003). The enzyme was
shown to be a methylase as it was able to incorporate radiolabeled methyl groups into the 30S
ribosome. As opposed to ArmA, this newly identified enzyme showed both sequence and
functional similarities to the 16S rRNA methylases of aminoglycoside-producing actinomycetes
(Yokoyama, K., et al, 2003; Yamane, K., et al, 2004; Yamane, K., et al, 2005). Also, the G+C
content of the rmtA gene is about 55%, which is similar to aminoglycoside-producing organisms.
Thus, these studies support a possible horizontal gene transfer from aminoglycoside-producing
microorganisms to P. aeruginosa (Yokoyama, K., et al, 2003; Yamane, K., et al, 2004; Yamane,
K., et al, 2005). In fact, it has been proposed that gene rmtA may have been transferred by a
mobile genetic element such as Tn5041 (Yamane, K., et al, 2004; Yamane, K., et al, 2005).
Recently, another 16S rRNA methylase was isolated in Japan (Doi, Y., et al, 2004). This
plasmid-borne methylase was isolated from Serratia marcescens and confers high-level
resistance to aminoglycosides, including the kanamycins and gentamicins. The enzyme shares
82% identity with RmtA, so it was named RmtB (Yokoyama, K., et al, 2003; Doi, Y., et al,
2004; Yamane, K., et al, 2005). Its origin is also suspected to be from aminoglycoside producing
organisms (Doi, Y., et al, 2004; Yamane, K., et al, 2005). Interestingly, ribosomal methylase
genes have also been detected, encoded as gene cassettes, in a culture-independent gene cassette
screening study (Nield, B.S., et al, 2004).
1.8 Objectives
The objectives of this study were to identify the gene or genes that contribute to highlevel gentamicin resistance in bacteria isolated from environmental samples with turtle farming
activity in Louisiana, and to determine their incidence in these bacteria, particularly Salmonella
spp. Additionally, to explore the molecular elements that contribute to the dissemination of
gentamicin resistance among bacteria isolated at the turtle farms.
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1.9 Relevance of Study
The work presented in this thesis is among the first to report high-level gentamicin
resistance in Gram-negative bacteria. It constitutes one of the first reports of aminoglycoside
resistance genes aac(3)IIa and aac(3)VIa in environmental isolates of Salmonella enterica subsp.
arizonae. Additionally, this study illustrates the potential of transfer of antibiotic resistance
genes, particularly gentamicin resistance, among bacteria in an environment with turtle farming
activity, a matter of particular concern as it involves the zoonotic pathogen Salmonella spp.
This research provides epidemiological data describing the resistance to aminoglycosides
currently used both in the turtle farms and in the clinical setting. The data presented highlights
the current inefficacy of the antibiotic gentamicin to eradicate Salmonella spp. from turtle eggs.
We hope to persuade the relevant authorities in Louisiana to revise the mandate to use
gentamicin for turtle egg treatment and to stress the need to develop new treatments to eradicate
Salmonella from turtle hatchlings.
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CHAPTER 2:
PLASMID-MEDIATED HIGH-LEVEL GENTAMICIN RESISTANCE AMONG
BACTERIA ISOLATED FROM TURTLE FARMS IN LOUISIANA *

* Reprinted by permission of Applied and Environmental Microbiology
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2.1 Introduction
Turtle farming has been an important economic activity in the state of Louisiana since
the 1930s (Siebeling, R.J., et al, 1975b). The sale of small carapace turtles, Pseudemys
(Trachemys) scripta elegans, was banned in 1975 in the United States’ domestic pet market by
the FDA due to concerns about their excretion of the human pathogen Salmonella spp.
(Siebeling, R.J., et al, 1975a; Cohen, M.L., et al, 1980; Shane, S.M., et al, 1990). Estimates in
the 1970s indicated that approximately 3x105 cases of human salmonellosis could be traced to
pet turtles (Siebeling, R.J., et al, 1975a; Cohen, M.L., et al, 1980), reportedly accounting for
14% of Salmonella spp. infections per year (Cohen, M.L., et al, 1980). In spite of the domestic
ban on the sale of baby turtles, the export market has continued to thrive. Around 12 million
hatchlings enter the export market each year to Western Europe, South America and Asia
(Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984; Izadjoo, M.J., et al, 1987). Prior to
export, hatchlings must be certified Salmonella-free by independent FDA-approved
laboratories (Siebeling, R.J., et al, 1984). This test involves enrichment and isolation of
Salmonella spp. by classic bacteriological assays performed on representative turtle samples
obtained at the farms (Siebeling, R.J., et al, 1975b; Siebeling, R.J., et al, 1975a; Siebeling, R.J.,
et al, 1984). In order to eradicate Salmonella spp. from turtle eggs, turtle farms follow a
modified version of the protocol used in the turkey farm industry to treat eggs, known as the
pressure-differential gentamicin egg-dip procedure (Saif, Y.M. and Shelly, S.M., 1973;
Greenfield, J., et al, 1975; Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). This FDAapproved treatment involves cleaning fresh-picked eggs by immersing them in a 380 ppm
Clorox bath and next treating them in a gentamicin sulfate (Garasol; Shering Corp.,
Bloomfield, N.J.) solution at 1000 ppm (µg/ml) (Siebeling, R.J., et al, 1975b; Michael-Marler,
S., et al, 1983; Siebeling, R.J., et al, 1984). The use of gentamicin for the treatment of turtle
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eggs presents various advantages at a commercial turtle farm level, since it does not lose its
antimicrobial activity when in solution or when exposed to freezing or autoclaving
temperatures (Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984).
Gentamicin belongs to the aminoglycoside family of antibiotics. The two major classes
of 2-deoxystreptamine aminoglycosides are the 4,5-disubstituted molecules, which include
neomycin, paramomycin, and ribostamycin, and the 4,6-disubstituted molecules, which include
gentamicin, kanamycin and amikacin (Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998;
Vakulenko, S.B. and Mobashery, S., 2003). Aminoglycosides are highly-potent, broadspectrum, bactericidal antibiotics that are often used in combination therapy with cell wall
active agents to treat infections caused by Gram-positive organisms such as Staphylococcus
aureus and streptococci (Miller, G.H., et al, 1997; Wright, G.D., et al, 1998; Vakulenko, S.B.
and Mobashery, S., 2003) as well as intracellular bacteria (Maurin, M. and Raoult, D., 2001;
Vakulenko, S.B. and Mobashery, S., 2003). Gram-negative aerobic bacilli are also sensitive to
these antibiotics, which makes them a treatment of choice for these infections (Wright, G.D., et
al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Aminoglycoside antibiotics act by
inhibiting prokaryotic protein synthesis (Davis, B.D., 1987; Mazel, D. and Davies, J., 1999).
They induce misreading of the genetic code by binding to the 16S ribosomal RNA A-site in
bacteria (Moazed, D. and Noller, H.F., 1987; Carter, A.P., et al, 2001). The most important
mechanism of aminoglycoside resistance is the enzymatic modification of the antibiotic by
aminoglycoside modifying enzymes, which are divided according to their enzymatic activity
into

the

aminoglycoside

phosphoryltransferases

(APHs),

the

aminoglycoside

nucleotidyltransferases (ANTs) and the aminoglycoside acetyltransferases (AACs) (Davis,
B.D., 1987; Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery,
S., 2003). In spite of the resistance problems that have arisen since the early 1970s and their
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relatively high toxicity to the host, they are still antibiotics of clinical choice, especially in
combined therapeutic use with β-lactams (Miller, G.H., et al, 1997; Wright, G.D., et al, 1998;
Vakulenko, S.B. and Mobashery, S., 2003).
Antibiotic use constitutes a selective pressure which can ultimately result in the
emergence of resitant strains; thus, bacteria resistant to a particular antibiotic are often detected
following its implementation or use (Davies, J. and Smith, D.I., 1978; Miller, G.H., et al, 1997;
Levy, S.B., 1998; Mazel, D. and Davies, J., 1999). Gentamicin resistance in Salmonella spp.
isolated from pet turtles was originally reported in Canada, in a 1990 study stating that turtles
imported from Louisiana carried gentamicin-resistant Salmonella spp. (D'Aoust, J.Y., et al,
1990). Concerns of the emergence of gentamicin-resistant Salmonella enterica subsp. arizonae
which could survive gentamicin treatment had been previously reported in the turkey farm
industry (Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). In July of 1999, several
Louisiana pet turtle export shipment lots failed certification. We received bacterial isolates
from failed-lot turtle samples from the certification laboratory, and we detected strains that
were resistant to concentrations of gentamicin >2000 µg/ml. The goal of the present study was
to identify the gene or genes which contribute to the high-level gentamicin resistance
phenotype observed in enteric bacteria, particularly Salmonella spp., from environmental
samples with turtle farming activity in Louisiana, and to determine the incidence of such genes
in the turtle farm environment.
2.2 Materials and Methods
2.2.1. Sample Recovery, Bacterial Isolation and Identification
The main geographical areas in Louisiana where turtle farming is conducted are Pierre
Part, Jonesville and Ponchatoula (Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984;
Izadjoo, M.J., et al, 1987). Samples were taken from various commercial pet turtle farms in
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Louisiana during the egg-laying season (April through September), from 1999 to 2002.
Samples were individually taken at different steps of the egg sanitation process, since each step
involved different exposures to gentamicin (GEN): 1) turtle hatchlings which had failed the
Certification assay (i.e., they were excreting Salmonella spp.) and which were provided by
Central Analytical Laboratories, Belle Chase, LA (Siebeling, R.J., et al, 1975a; MichaelMarler, S., et al, 1983); 2) eggs, which were collected directly from dirt nests and which had
not yet been treated with GEN; 3) the 1000 µg/ml GEN solution used to treat eggs and 4) water
from pet turtle farm ponds. Each sample was taken separately and only one isolate of each
genus and species was recovered per sample, to avoid double inclusion of the same isolate.
Samples were enriched for Salmonella spp. using selenite cistine broth (Difco, Detroit, MI),
and isolated on bismuth sulfite (Difco) plates as previously described (Siebeling, R.J., et al,
1975a; Siebeling, R.J., et al, 1984). Gram-negative bacteria were routinely grown at 37oC using
McConkey (Difco) plates. Isolates were identified using API-20E or API-NE (bioMérieux SA,
Marcy l'Etoile, France). Conjugation assays were done using Heart Infusion (HI) media
(Difco). Laboratory strains were grown using Luria-Bertani (LB) media (Sambrook, J., et al,
1989). All GEN-resistant strains were propagated in media supplemented with 100 µg/ml GEN.
A summary of all laboratory bacterial strains and plasmids used in this study is found in Table
2.1.
2.2.2. Antibiotic Susceptibility Assays
The minimal inhibitory concentration (MIC) assays were performed in microdilution plates,
using Mueller-Hinton (MH) broth (Difco), following the procedure recommended by the
National Committee for Clinical Laboratory Standards (NCCLS) (NCCLS, 1999), using the
following aminoglycoside antibiotics: GEN, kanamycin (KAN), streptomycin (STR), neomycin
(NEO), tobramycin (TOB), amikacin (AMK), netilmicin (NET) and sisomicin (SIS) (Sigma, St.
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Table 2.1. Bacterial Strains and Plasmids Used in This Study
Strain or plasmid

Relevant characteristics

Source or Reference

Laboratory strains
E. coli TOP10

Electrocompetent or chemically competent. FmcrA ∆(mrr-hsdRMS-mcrBC)
Ф80lacZ∆M15 ∆lacX74 recA1 deoR
araD139 (ara-leu)7697 galU galK rpsL (Strr)
endA1 nupG
GENs (MIC: <3.9 µg/ml)

E. coli strain BM14

AZI; GENs (MIC: <3.9 µg/ml)

Invitrogen

8

Environmental strains
S. enterica subsp. enterica,
strain S5

GEN KAN TOB; GEN MIC: >2000 µg/ml

turtle nest eggs a

S. enterica subsp. arizonae,
strain A40

GEN KAN TOB; GEN MIC: >2000 µg/ml

infected turtles b

S. enterica subsp. arizonae,
strain PH5

GEN KAN TOB; GEN MIC: >2000 µg/ml

turtle pond water c

E. cloacae, strain E19

GEN KAN TOB; GEN MIC: >2000 µg/ml

infected turtles b

C. freundii, strain C14

GEN KAN TOB; GEN MIC: >2000 µg/ml

turtle nest eggs a

Plasmids
pGEM®-7Zf

cloning and sequencing vector; AMP

Promega

pCR2.1-TOPO

cloning and sequencing vector; KAN

Invitrogen

(table cont’d)
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pSal5

R-plasmid isolated from S. enterica subsp.
enterica, strain S5

this study

pAri40

R-plasmid isolated from S. enterica arizonae,
strain A40

this study

pAriPH5

R-plasmid isolated from S. enterica subsp.
arizonae, strain PH5

this study

pEnt19

R-plasmid isolated from E. cloacae, strain E19

this study

pCit14

R-plasmid isolated from C. freundii, strain C14

this study

pGSal5h

pGEM®-7Zf derivative containing a 5.5 kb
HindIII fragment from pSal5

this study

pGEnt19b

pGEM®-7Zf derivative containing a 5.0 kb
BamHI fragment from pEnt19

this study

a

isolated from nest egg homogenate (26, 37, 38) at the Louisiana turtle farms, July 1999; b supplied by
Central Analytical Laboratory, Belle Chase, LA, July 1999, c isolated from turtle breeding pond water
in Louisiana, June 2000. Abbreviations: AMP, ampicillin; AZI, sodium azide; GEN, gentamicin;
GENs, gentamicin sensitive; KAN, kanamycin; TOB, tobramycin.
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Louis, MO). In all cases, the starting antibiotic concentration tested was 2000 µg/ml serially
diluted two-fold to 3.9 µg/ml.
The Kirby-Bauer disk-diffusion assay was performed using MH agar plates according
to NCCLS standards (NCCLS, 1999); using the following antibiotics: GEN (10 µg), KAN (30
µg), TOB (10 µg), AMK (30 µg), ampicillin (AMP) (10 µg), tetracycline (TET) (30 µg),
chloramphenicol (CHL) (30 µg), polymixin B (PMB) (300 units), cephalothin (CEF) (30 µg),
cefotaxime (CTX) (30 µg), trimethoprim (TMP) (5 µg) and nitrofurantoin (NIT) (300 µg)
(Difco). Inhibition zone breakpoints were interpreted according to information supplied by the
manufacturer and to NCCLS standards (NCCLS, 1999).
2.2.3. R-Plasmid Isolation and Characterization
Conjugation was done to detect plasmids carrying GEN-resistance determinants. In
each bacterial mating experiment, a GEN-resistant organism was used as the donor.
Representative isolates of each genus and species (chosen based on similar resistance
phenotypes) were used as donors and included S. enterica subsp. enterica serovar Enteritidis, S.
enterica subsp. arizonae, E. cloacae, C. freundii, P. aeruginosa, Acinetobacter baumanii,
Stenotrophomonas maltophilia, Proteus vulgaris and Providencia stuartii. E. coli strain BM14,
resistant to sodium azide (AZI) was used as the recipient (Cloeckaert, A., et al, 2000). Bacterial
mating was done by mixing 1 ml of a log-phase culture of GEN-resistant donor cells with 4 ml
of log-phase recipient AZI-resistant E. coli BM14 cells and incubating at 37°C for 16 hours,
with no shaking. Transconjugant AZI-resistant, GEN-resistant E. coli colonies were selected on
HI plates supplemented with 100 µg/ml GEN and 500 µg/ml AZI.
R-plasmids from GEN-resistant bacteria were purified using QIAfilter plasmid kits
(Qiagen, Valencia, CA), following instructions provided by the manufacturer for low copy
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number plasmids. Plasmids were eluted in molecular grade water at 65oC and stored at -20oC.
To minimize the possibility of working with strains carrying more than one plasmid
(mobilizable plasmids that might co-transfer during conjugation) and to better assess the
resistance phenotypes (AZI-resistant transconjugant E. coli have a slower growth rate),
plasmids isolated from transconjugants were used to transform naïve OneShot TOP10 E. coli
cells (Invitrogen, Carlsbad, CA), using a Bio-Rad Gene Pulser II electroporator (BioRad,
Hercules, CA), following recommendations from the manufacturer. Briefly, 50 µl
electrocompetent cells were transferred to a chilled 0.1 cm cuvette with 1-2 µl of diluted
plasmid DNA. Pulses were given at 2.0 kV, 25 µF and 100-200 Ω for 5 msec. Transformant
GEN-resistant E. coli cells were selected on LB plates supplemented with 100 µg/ml GEN.
To compare their restriction fragment profiles, R-plasmids were isolated as described
above from environmental GEN-resistant isolates, transconjugant E. coli, and transformant E.
coli cells. DNA concentration of uncut plasmids was estimated by comparison to Supercoiled
Plasmid DNA ladder (Bayou Biolabs, Harahan, LA), after 0.5% Agarose I (Sigma) in 0.5x
TBE (BioRad) gel electrophoresis migration. R-plasmids were digested separately with EcoRI,
HindIII or BamHI (New England Biolabs, Beverly, MA), following recommendations from the
manufacturer for each restriction enzyme. Restriction enzyme digestion profiles were assessed
using 0.5% agarose III (Amresco, Solon, OH) gel electrophoresis in TAE buffer (Sambrook, J.,
et al, 1989). The 1 kb DNA ladder and λ DNA-Hind III Digest (New England BioLabs) were
used as molecular size standards. Image analysis was done by UV transillumination of ethidium
bromide-stained gels using the Quantity One imaging software (BioRad).
The sizes of the large R-plasmids were estimated using Pulse Field Gel Electrophoresis.
Briefly, 0.8% Pulse Field Electrophoresis Agarose (Sigma) plugs were made with R-plasmids
isolated as described above. Agarose plugs were loaded onto a 90 ml, 1% agarose (Sigma) gel
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in 0.5x TBE buffer and run in 0.5x TBE buffer using a CHEF–DR II system (BioRad).
Electrophoresis was run for 22 h at 6 V/cm, 120o and 14ºC with switch times ramping 1-25
seconds. The Midrange I PFG Marker (New England BioLabs) and the BAC-TrackerTM
Supercoiled DNA Ladder (Epicentre Biotechnologies, Madison, WI) were used as a molecular
size standards. Image analysis was done after staining with ethidium bromide, using Quantity
One imaging software.
2.2.4. Cloning and Identification of GEN-Resistance Gene(s)
A vast number of genes are known to confer GEN resistance in Gram-negative bacteria
(Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003).
To determine which gene(s) confer GEN resistance in the isolates of this study, these were
cloned and sequenced as follows: R-plasmids isolated as described above were digested with
EcoRI, HindIII or BamHI, according to the manufacturer’s recommendations. Restriction
fragments were purified using QIAquick Spin columns (Qiagen) and ligated into previously
digested pGEM®-7Zf (Promega, Piscataway, NJ). Ligation reactions were used to transform E.
coli TOP10 chemically competent cells (Invitrogen) following the protocol provided by the
manufacturer. Recombinant clones carrying GEN-resistance determinants were selected on LB
plates supplemented with 100 µg/ml GEN and 50 µg/ml AMP. Recombinant plasmids were
purified with QIAprep Spin columns (Qiagen) and inserts were sequenced using the vector’s
internal sequencing primers.
2.2.5. Sequencing and Computer Analysis
Sequencing was done with fluorescent dye-labeled dideoxynucleotides with an ABI
Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA). Sequence analysis was
done using VectorNTI (Invitrogen), BLAST (Altschul, S.F., et al, 1997) and GeneBank
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(National

Center

for

Biotechnology

Information,

available

through

http://www.ncbi.nlm.nih.gov/BLAST/).
2.2.6. Screening for GEN Resistance Genes
Multiplex PCR assays were designed to screen environmental isolates for the GENresistance genes that were identified through cloning and sequencing of GEN resistance
determinants. Multiplex PCR reactions included primers to detect resistance genes aac(3)IIa
and aac(3)VIa, as well as a fragment of the 16S rRNA gene as an internal control for each
reaction (Vliegenthart, J.S., et al, 1990). Primers were designed using Vector NTI (Invitrogen).
PCR screening of genes intI and sul1, commonly associated with class 1 integrons (Stokes,
H.W. and Hall, R.M., 1989; White, P.A., et al, 2001), and of armA, rmtA and rmtB, the only
genes reported to confer high level aminoglycoside resistance in Gram-negative bacteria
(Yamane, K., et al, 2005), was done in separate reactions using published primers (Schwocho,
L.R., et al, 1995; Sunde, M. and Sorum, H., 1999; Galimand, M., et al, 2003; Yokoyama, K., et
al, 2003; Doi, Y., et al, 2004; Yamane, K., et al, 2005). All primers used are summarized in
Table 2.2. To prepare DNA for PCR, pelleted cells from 1 ml of overnight cultures were
resuspended in 100 µl dH2O and lysed through two 5 min. freeze-boil cycles. 2 µl of the
supernatants were used as templates in 50 µl PCR reactions. PCR was done using the
FailSafe™ PCR System with buffer “G” (Epicentre Biotechnologies) according to instructions
provided by the manufacturer. Thermocycler conditions were set as follows: [1X (96oC, 5 min);
35X (96oC, 30 sec; 58oC, 30 sec; 70oC, 60 sec); (70oC, 7 min)]. To amplify the armA gene,
PCR was done using the same conditions stated above, but various annealing temperatures
(40oC, 42.2oC, 44.1oC, 46.9oC, 48.9oC, 50.2oC and 51oC) were assayed in different reactions.
PCR products were visualized by agarose gel electrophoresis using 2% Agarose I in 0.5x TBE
buffer and staining with ethidium bromide. Some PCR products were sequenced to confirm
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Table 2.2. Primers Used for PCR and Sequencing
PCR target

Primer

aac(3)-IIa

aacIIaF
aacIIaR
aacVIaF
aacVIaR
metF
metR
RMTA-F
RMTA-R
MBH-F
MBH-R
intIF
intIR
sulF1
sulR
rrn1A
rrn2B
M13F (-20)
M13R

aac(3)-VIa
armA
rmtA
rmtB
intI1
sul1
rrn

Amplicon size
Sequence (5' → 3')
(bp)
900
465
777
634
771
845
840
330
variable

GGG
CAT
CGC
CAT
CAA
TTA
CTA
TTT
GGA
CCG
CTA
GGG
ATG
CTA
TAA
CCC
GTA
CAG

AAT
TGT
TCA
AAT
ATG
TTT
GCG
GCT
ATT
CTC
CCT
CAG
GTG
GGC
CAC
ATT
AAA
GAA

TCA
CGA
GGC
GGA
GAT
CTG
TCC
TCC
CCA
GAG
CTC
CAG
ACG
ATG
ATG
GTG
CGA
ACA

GAG
CGG
GAT
GCG
AAG
AAA
ATC
ATG
TAT
TCC
ACT
CGA
GTG
ATC
CAA
CAA
CGG
GCT

* E.C. Achberger, personal communication
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Accession No.
(Reference)
GAG
CCT
ATG
CGG
AAT
TCC
CTT
CCC
GAA
ATT
AGT
AGT
TTC
TAA
GTC
TAT
CCA
ATG

ATA
CTA
GTG
TGA
GAT
ACT
TCC
TTG
CAT
CTT
GAG
CGA
GGC
CCC
GAA
TCC
G
AC

TCG CGA TGC ATA CG
ACC
AT
CT
GAT GAT
TC
CC
CAA CGA TGC CCT
TTT TAT CAA GTA
GGG CGG
GGC
AT
TC
CG
CC

X13543 (*)
L22613 (*)
AY220558 (18)
AB083212 (46)
AB103506 (13)
X15852 (34,40)
U12441 (18,40)
(43)
(Invitrogen)

amplification of the appropriate genes and to compare with published sequences in the
databases. For sequencing, PCR products were purified using QIAquick Spin columns and
ligated into pCR2.1-TOPO using the TOPO-TA cloning kit (Invitrogen), as suggested by the
manufacturer. Sequencing of appropriate clones was done using the internal vector sequencing
primers, as described above.
2.3 Results
2.3.1. Gentamicin Resistance in Turtle Farms
Bacterial genera and species recovered from the turtle farm setting are summarized in
Table 2.3, and they include S. enterica subsp. enterica, S. enterica subsp. arizonae, E. cloacae,
C. freundii, P. aeruginosa, A. baumanii, S. maltophilia, A. faecalis, P. vulgaris and P. stuartii.
The antibiotic resistance phenotypes of the organisms tested show that in addition to resistance
to GEN, these organisms exhibited resistance to other aminoglycosides such as KAN and TOB,
but not to AMK. Some organisms were also resistant to AMP (Table 2.3). Organisms such as
P. aeruginosa and S. maltophilia were resistant to the majority of the antibiotics assayed.
As summarized in Table 2.3, the majority of GEN-resistant bacteria displayed highlevel resistance to GEN (MIC>2000 µg/ml). GEN-sensitive bacteria were primarily recovered
from untreated eggs and breeding ponds and presented GEN MICs from <3.9-7.8 µg/ml (Table
2.3), whereas the majority of isolates recovered from contaminated turtles and the GEN dip
solutions showed elevated resistance to GEN. Nevertheless, GEN-resistant isolates recovered
from untreated eggs and breeding ponds also expressed high-level of resistance. E. coli strain
BM14, E. coli OneShot TOP10, and E. coli ATCC 25922, used as GEN-sensitive controls, had
GEN MICs <3.9-7.8 µg/ml (Table 2.1).
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Table 2.3. Prevalence of Gentamicin Resistance Genes Among Bacterial Isolates From Turtle Farms
Samplea

Identifed organism

Resistance phenotype b

43
20
4

7 (16)
3 (15)
2 (50)

S. enterica subsp. arizonae
Stenotrophomonas maltophilia

38
7

4 (11)
3 (43)

Citrobacter freundii
Enterobacter cloacae
Escherichia coli
Proteus vulgaris

49
44
3
1

Pseudomonas aeruginosa

12

S. enterica subsp. enterica
S. enterica subsp. arizonae

4
53

6 (12) GEN KAN TOB
2 (5) GEN KAN TOB
1 (33) GEN KAN TOB
1 (100) GEN AMP NIT PMB
(TMP)
5 (42) GEN KAN TOB AMP
(CHL) (CTX) NIT (TET)
TMP
2 (50) GEN KAN TOB
11 (21) GEN KAN TOB

Pond water Citrobacter freundii
Enterobacter cloacae
Pseudomonas aeruginosa

Nest eggs

Number GENr
collected n (%)

GEN soln. Acinetobacter baumannii
Alcaligenes xylosoxidans

1
2

Pseudomonas aeruginosa

3

GEN KAN TOB
GEN KAN TOB
GEN KAN TOB AMP
(CHL) (CTX) NIT (TET)
TMP
GEN KAN TOB
GEN KAN TOB AMP
(CHL) (CTX) NIT (TET)
TMP

1 (100) GEN KAN TOB AMP TMP
2 (100) GEN KAN TOB AMP
(CHL) CTX NIT TET TMP
3 (100) GEN KAN TOB AMP
(CHL) CTX NIT TET TMP

GEN MIC
% Incidence d
c
(µg/ml)
aac(3)IIa aac(3)VIa
>2000
>2000
>2000

43
100

57
100
-

>2000
>2000

100

100
-

>2000
>2000
>2000
500

33
100

67
100
100
-

>2000

100

-

>2000
>2000

100
-

100

>2000
>2000

100
100

-

>2000

100

-

(table cont’d)
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Turtles

Pseudomonas fluorescens

2

2 (100) GEN KAN TOB AMP (CHL)
(CTX) NIT (TET) TMP

>2000

100

-

Alcaligenes faecalis
Citrobacter freundii
Enterobacter cloacae
Escherichia coli
Proteus vulgaris
Providencia stuartii
Pseudomonas aeruginosa

1
4
3
1
2
3
8

1 (100)
4 (100)
3 (100)
1 (100)
2 (100)
3 (100)
5 (63)

>2000
>2000
>2000
>2000
500
500
>2000

100
100
100
100

100
100
100
-

S. enterica subsp. arizonae

28

>2000

-

100

GEN KAN TOB AMP TMP
GEN KAN TOB
GEN KAN TOB
GEN KAN TOB
GEN AMP NIT PMB (TMP)
GEN AMP NIT PMB (TMP)
GEN KAN TOB AMP (CHL)
(CTX) NIT (TET) TMP
28 (100) GEN KAN TOB

a

Samples were taken from nest egg homogenate, turtle breeding pond water and GEN soln., as previously described (26, 37,
38), at turtle farms in Louisiana, 1999-2002. Infected turtle isolates were supplied by Central Analytical Laboratory, Belle
Chase, LA, July 1999. b Resistance phenotype and c MIC value displayed by >90% of GEN resistant isolates, for each genus
and species. GEN sensitive isolates presented GEN MIC <3.9-7.8 µg/ml. d % GEN resistant strains carrying aac(3)IIa or
aac(3)VIa. Abbreviations: AMP, ampicillin; CHL, chloramphenicol; CTX, cefotaxime; GEN, gentamicin; GENr, GEN
resistance; GEN soln., GEN egg dip solution (1000 µg/ml); KAN, kanamycin; NIT, nitrofurantoin; PMB, polymixin B; TET,
tetracycline; TMP, trimethoprim; TOB, tobramycin; antibiotics in parenthesis denote intermediate resistance.
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2.3.2. R-plasmid Isolation
When checked for plasmids, environmental GEN-resistant isolates showed one or more
plasmids. Nevertheless, transconjugant E. coli resistant to GEN and AZI were obtained only
from the strains of S. enterica subsp. enterica, S. enterica subsp. arizonae, E. cloacae and C.
freundii. Transconjugants' GEN MICs were all >2000 µg/ml. Likewise, the antibiograms were
similar between donor organisms and their E. coli transconjugants. Furthermore, OneShot
TOP10 E. coli cells transformed with R-plasmids isolated from these transconjugants acquired
the same resistance phenotypes as the transconjugant from which the R-plasmid had been
isolated. The resulting phenotypes and genotypes of these transformant E. coli are summarized
in Table 2.4.
2.3.3. Identification of GEN Resistance Gene(s)
R-plasmid pSal5 was isolated from GEN-resistant E. coli obtained after transformation
with plasmids from S. enterica (strain S5) (Table 4). Recombinant plasmid pGSal5h was
obtained from a 5.5 kb HindIII restriction fragment of pSal5 that was ligated into pGEM®-7Zf.
Sequence analysis of this GEN-resistant clone revealed the presence of the aminoglycoside
resistance gene aac(3)IIa, which was 98% identical to that in GenBank database accession no.
X13543 (Brau, B., et al, 1984; Allmansberger, R., et al, 1985; Vakulenko, S.B. and Mobashery,
S., 2003).
Preliminary screening to detect gene aac(3)IIa in other environmental isolates revealed
that some GEN-resistant organisms did not carry aac(3)IIa. Thus, R-plasmid pEnt19, originally
from E. cloacae (strain E19) (Table 2.4), was used for cloning and sequencing since this
plasmid conferred GEN resistance, but did not carry aac(3)IIa. Recombinant plasmid
pGEnt19b was obtained from a 5 kb BamHI fragment of R-plasmid pEnt19 ligated into

64

Table 2.4. R-Plasmids Isolated From Bacteria Recovered From Turtle Farms
Plasmid

Size
(kb)

RFLP
type

Resistance
phenotypea

pSal5
pAri40
pAriPH5
pEnt19
pCit14

ca. 45
ca. 145
ca. 145
ca. 115
ca. 45

A
B
B
C
D

GEN KAN TOB
GEN KAN TOB
GEN KAN TOB
GEN KAN TOB
GEN KAN TOB

a

GEN MIC
GEN resistance and integron-associated genes b
a
(µg/ml)
aac(3)IIa aac(3)VIa armA rmtA rmtB intI1 sul1
>2000
>2000
>2000
>2000
>2000

+
+

+
+
+
-

-

determined using transformant TOP10 E. coli cells; b as determined by PCR and/or sequencing
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-

-

+
+
+
-

+
+
+
+
-

pGEM®-7Zf. Sequence analysis of pGEnt19b revealed the presence of aminoglycoside
acetyltransferase gene aac(3)VIa, which was 99% identical to that in GenBank database
accession no. L22613 (Rather, P.N., et al, 1993). Sequencing and PCR additionally revealed
integron class 1 associated genes intI1 and sul1 (Table 2.4), indicating the presence of
aac(3)VIa as a gene cassette of a class-1 integron.
Genes aac(3)IIa or aac(3)VIa have not been reported in the literature to confer highlevel GEN resistance (Brau, B., et al, 1984; Allmansberger, R., et al, 1985; Rather, P.N., et al,
1993; Vakulenko, S.B. and Mobashery, S., 2003). We thus attempted to amplify by PCR the
16S rRNA methylase genes recently reported in the literature which do confer a high-level
aminoglycoside resistance phenotype in Gram-negative bacteria, namely armA (Galimand, M.,
et al, 2003), rmtA (Yokoyama, K., et al, 2003; Yamane, K., et al, 2004) and rmtB (Doi, Y., et
al, 2004). Nevertheless, these genes were not detected in the isolates tested (Table 2.4).
2.3.4. Distribution of GEN Resistance Genes in Bacterial Isolates From Turtle Farms
Multiplex PCR assays designed to screen for the presence of resistance genes aac(3)IIa
and aac(3)VIa on bacterial isolates from turtle farms (N=336), revealed that every GENresistant organism tested carried either one of these acetyltransferase genes (Table 3). Gene
aac(3)IIa was present in 37% of the GEN-resistant isolates tested (n=101); it was detected
mainly in non-fermentors but was also found in S. enterica subsp. enterica and C. freundii.
Gene aac(3)VIa accounted for 94% of GEN resistance in Salmonella spp. (n=35). Neither gene
was detected in GEN-sensitive organisms, including GEN-sensitive controls previously
described. intI1 was detected by PCR in all GEN-resistant bacteria carrying aac(3)VIa, but not
in organisms carrying aac(3)IIa.
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HindIII
1

kbp

2

BamHI
3

4

5

6

23.130

9.416
6.557

►

◄

4.361

◄

2.322
2.027

Figure. 2.1. HindIII and BamHI digestion profiles of R-plasmids pSal5
(lanes 1 & 4), pAri40 (lanes 2 & 5) and pEnt19 (lanes 3 & 6). λ-DNA-Hind
III digest, used as a molecular standard, is indicated on the left. Arrowheads
indicate bands carrying genes aac(3)IIa (►) and aac(3)VIa (◄).

67

2.3.5. Plasmid Heterogeneity
R-plasmids pSal5, pAri40, and pEnt19 showed different HindIII and BamHI RFLP
profiles (Figure 2.1). Multiplex PCR of resistance genes aac(3)IIa and aac(3)VIa (Table 2.4)
plus hybridization of these genes with digested R-plasmids (Figure 2.1) showed that pSal5
carried aac(3)IIa, and that pAri40 and pEnt19 carried aac(3)VIa, confirming that these genes
are plasmid-borne. The mentioned R-plasmids differed in size as well, as visualized after PFGE
and ethidium bromide staining. These results are summarized in Table 2.4.
2.4 Discussion
Turtles and other reptiles are known to excrete S. enterica subsp. arizonae and other
salmonellae (Cohen, M.L., et al, 1980; D'Aoust, J.Y., et al, 1990; Ebani, V.V., et al, 2005). The
GEN resistance that has emerged in the last decade presents a threat to the efficacy of the GEN
sulfate treatment used by the turtle industry to eradicate Salmonella spp. In this study, we found
two genes which are carried by bacteria recovered from environmental samples with turtle
farming activity which confer high-level GEN resistance. These genes are aac(3)IIa and
aac(3)VIa, which code for aminoglycoside acetyltransferase enzymes (Brau, B., et al, 1984;
Allmansberger, R., et al, 1985; Rather, P.N., et al, 1993). Gene aac(3)IIa presents the
AAC(3)II aminoglycoside resistance pattern phenotype, which involves resistance to GEN,
TOB, SIS, NET, and DBK (Brau, B., et al, 1984; Allmansberger, R., et al, 1985; Shaw, K.J., et
al, 1993; Vakulenko, S.B. and Mobashery, S., 2003). These genes are reported to be detected in
Gram-negative bacteria in the clinical setting with a relatively higher frequency (18-60%) with
respect to other aminoglycoside resistance patterns (Shaw, K.J., et al, 1993; Miller, G.H., et al,
1997; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Gene aac(3)IIa,
originally identified in R-plasmids (Allmansberger, R., et al, 1985), reportedly accounts for
85% of the AAC(3)-II phenotype (Miller, G.H., et al, 1997; Wright, G.D., et al, 1998;
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Vakulenko, S.B. and Mobashery, S., 2003). The AAC(3)-VI resistance pattern, includes
resistance to GEN (Rather, P.N., et al, 1993; Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998;
Vakulenko, S.B. and Mobashery, S., 2003). The gene aac(3)VI was originally cloned from a
conjugative plasmid of E. cloacae and rarely occurs among clinical isolates (Rather, P.N., et al,
1993; Vakulenko, S.B. and Mobashery, S., 2003). Its deduced amino acid sequence shares 50%
amino acid similarity with the aac(3)-IIa gene (Rather, P.N., et al, 1993; Shaw, K.J., et al,
1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003).
The majority of aminoglycoside modifying enzymes can provide effective resistance to
aminoglycosides, but only certain phosphotransferase enzymes detected in Gram-positive
bacteria have been reported to produce high-levels of resistance to these antibiotics (Ferretti,
J.J., et al, 1986; Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Chow, J.W., 2000;
Vakulenko, S.B. and Mobashery, S., 2003). When we started this study there had been no
reports, to the best of our knowledge, of the acquisition of genes conferring high-level
aminoglycoside resistance in environmental Gram-negative bacteria (M.A. Diaz, E.C.
Achberger, V.R. Srinivasan and R.J. Siebeling, Abstr. 100th Amer. Soc. Microbiol. Gen.
Meeting, abstr. Z-4, 2000). Recently however, Galimand et al (Galimand, M., et al, 2003)
found that the high-level aminoglycoside resistance phenotype in a clinical strain of Klebsiella
pneumoniae was due to the presence of the aminoglycoside resistance gene armA. This strain
of K. pneumoniae also presented genes aac(3)II, blaTEM1, blaCTX-M, dfrA12, sul1 and ant(3")9,
conferring resistance to aminoglycosides, β-lactams, trimethroprim, sulfonamides and
streptomycin-spectinomycin, respectively (Galimand, M., et al, 2003). In this study, we did not
detect gene armA by PCR in any of the isolates screened, in spite of detecting certain shared
elements in some of the strains, such as genes aac(3)IIa and sul1 (Table 4). We also screened
for two other high-level aminoglycoside resistance genes: rmtA, cloned and identified from a
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clinical isolate of P. aeruginosa AR-2 in Japan (Yokoyama, K., et al, 2003) and plasmid-borne
16S rRNA methylase rmtB, isolated from Serratia marcescens (Doi, Y., et al, 2004).
Nevertheless, we did not detect by PCR any other resistance gene that could act in synergy with
the already identified aac(3)IIa or aac(3)VIa gene products or by itself, to give the high-level
GEN resistance phenotype observed in the bacteria we isolated in the turtle farms.
The current study is the first to report the genes which confer GEN resistance to
bacteria in the turtle farm environment, namely aac(3)IIa and aac(3)VIa. PCR and sequencing
experiments confirmed that these resistance genes are present on mobile genetic elements that
can facilitate their horizontal transfer among bacteria in the environment (Allmansberger, R., et
al, 1985; Rather, P.N., et al, 1993; Fluit, A.C. and Schmitz, F.J., 1999; White, P.A., et al, 2001;
Heuer, H., et al, 2002; Carattoli, A., 2003). Both genes are found on R-plasmids of the
Enterobacteriacea (Brau, B., et al, 1984; Allmansberger, R., et al, 1985; Rather, P.N., et al,
1993). Until recently (Galimand, M., et al, 2003), only gene aac(3)VIa had been reported as a
gene cassette within a class 1 integron (Rather, P.N., et al, 1993; Wright, G.D., et al, 1998;
White, P.A., et al, 2001; Yamane, K., et al, 2005). Recent studies, however, have also detected
the aac(3)II gene surrounded by integron elements (Galimand, M., et al, 2003). In fact, the
molecular environment of armA gene has been depicted as a composite or complex integron
environment and is found downstream of orf513 coding for a putative recombinase or
transposase (Partridge, S.R. and Hall, R.M., 2003). We are currently conducting research to
examine the molecular environment of the genes found.
GEN-resistant isolates were more prevalent in samples where exposure to GEN was
greater, but were also detected in turtle pond water and nest eggs, consonant with the notion
that antibiotic use can favor the selection of resistant strains (Miller, G.H., et al, 1997; Levy,
S.B., 1998). The presence of these genes on mobile molecular elements can facilitate their
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transfer and spread among different bacteria in the turtle farm environment (Fluit, A.C. and
Schmitz, F.J., 1999; Heuer, H., et al, 2002; Carattoli, A., 2003). However, additional studies
are required to determine if the interspecies dissemination of these genes occurred at the turtle
farms. This study illustrates the potential of transfer of antibiotic resistance genes, particularly
GEN resistance, between different genera in the turtle farms, a matter of particular public
health concern as it involves the human pathogen Salmonella spp. The epidemiological data
presented stresses the need to develop an alternate method for the eradication of Salmonella
spp. from turtle eggs. This is the first study to describe the genes involved in GEN resistance in
S. enterica subsp. arizonae. It is important to monitor the presence of these resistance genes
and molecular transfer elements in bacteria like the salmonellae, since these cause zoonosis and
represent possible resistance reservoirs and can thus be important in the development of
multiresistance in bacteria (Boyd, D., et al, 2002; Carattoli, A., 2003; Ebani, V.V., et al, 2005),
as well as in its transfer between animals and humans.
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CHAPTER 3:
CULTURE-INDEPENDENT IDENTIFICATION OF BACTERIA PRESENT IN
GENTAMICIN SOLUTIONS USED TO ERADICATE
SALMONELLA SPP. FROM PET TURTLES
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3.1 Introduction
The sale of small turtles, Pseudemys (Trachemys) scripta elegans, has been an
important economic activity in the State of Louisiana since the 1930s (Siebeling, R.J., et al,
1975b; Cohen, M.L., et al, 1980). In spite of the domestic ban imposed on the sale of small
carapace turtles due to salmonellosis outbreaks that were traced back to these pets, the export
market has continued to thrive (Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984;
Izadjoo, M.J., et al, 1987). However, in order for baby turtles to be certified for export to
Europe, Asia and South America, Salmonella spp. must be eradicated from the turtles
(Siebeling, R.J., et al, 1975a; Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984). For
this, turtle farms follow a modified version of the FDA-approved pressure-differential
gentamicin treatment protocol used in the turkey farm industry (Saif, Y.M. and Shelly, S.M.,
1973; Greenfield, J., et al, 1975; Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). In brief,
turtle eggs are treated in a solution of 1000 ppm (µg/ml) gentamicin by the pressure differential
method to ensure penetration of the antibiotic into the eggs (Siebeling, R.J., et al, 1975b;
Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984). The use of the gentamicin sulfate
solution (Garasol; Shering Corp., Bloomfield, N.J.) was chosen for its practical advantage since
it has a stable shelf life and can be boiled and filtered, and it retains its bactericidal activity,
allowing the solution to be stored and reused after appropriate adjustments (Siebeling, R.J., et
al, 1975b; Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984).
Gentamicin belongs to the family of the aminoglycosides, which are highly-potent,
broad-spectrum bactericidal antibiotics, that are commonly used clinically in combination with
β-lactams for the treatment of Gram-positive organisms such as Staphylococcus aureus and the
streptococci as well as aerobic Gram-negative infections (Shaw, K.J., et al, 1993; Wright, G.D.,
et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Gentamicin is a 4,6-disubstituted 2-
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deoxystreptamine aminoglycoside (Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery,
S., 2003). Aminoglycoside antibiotics act by inhibiting prokaryotic protein synthesis (Davis,
B.D., 1987; Mazel, D. and Davies, J., 1999). They induce misreading of the genetic code by
binding to the 16S rRNA A-site in the bacterial ribosome (Moazed, D. and Noller, H.F., 1987).
Microorganisms can be intrinsically resistant or become resistant to aminoglycosides through a
variety of mechanisms, which include: 1) the alteration of the drug’s target through mutational
or enzymatic modifications of the ribosome; 2) the reduced uptake or accumulation of the drug,
generally by means of active efflux pumps; and 3) most frequently, the enzymatic modification
of the antibiotic molecule by aminoglycoside modifying enzymes (Shaw, K.J., et al, 1993;
Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003).
In recent years, using a bacteriological culturing approach, we have detected gentamicin
resistant organisms in commercial turtle farms in Louisiana (Diaz, M.A., et al, in press).
However, the assessment of the diversity of a microbial community can be largely
underestimated by these classic culturing techniques (Ward, D.M., et al, 1998; Hengstmann,
U., et al, 1999), and organisms which may contribute to maintaining the gentamicin resistance
gene pool in the turtle farms could be missed by conventional antibiotic resistance assays.
Therefore with this study we intended to identify, using a culture-independent approach,
organisms present in the 1000 µg/ml gentamicin sulfate treatment solutions used to eradicate
Salmonella spp. from turte eggs.
3.2 Materials and Methods
3.2.1. Sample Collection
Gentamicin (GEN) treatment solutions were collected in June, 2002 from pet turtle
farms in five different locations in Louisiana. Samples were collected observing sterile
conditions. The GEN dip solutions had been used and stored at the farms as usual, for 3-4 days
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to treat approximately 20,000 turtle eggs. The dip solutions had an original concentration of
1000 µg/ml GEN, which is recalibrated to this concentration to prior to reuse (Siebeling, R.J.,
et al, 1984). They were kept at 4ºC at the farms, then transported and stored for one year in our
laboratory at the same temperature.
3.2.2. DNA Extraction and Purification
Ten ml of each unfiltered GEN dip solution were centrifuged to pellet any bacterial
cells present in the treatment solution after the customary year of storage at 4oC. The pellet was
resuspended in 300 µl saline-EDTA (Sambrook, J., et al, 1989). Cells were lysed by adding 15
µl of lysozyme (BioRad, Hercules, CA) mixing and incubating for 30 min. at 37°C. This was
followed by adding 5 µl of Proteinase K (BioRad) and 10 µl SDS (10% w/v) (BioRad) and
incubating at 60°C for 10 min. and finally, performing 3 freeze–thaw cycles (10 min. at -80°C
followed by 10 min. at 60°C). 300 µl of the supernatants were stored at -20oC for further
analysis. The presence of DNA from the lysates was verified on 0.5% agarose I (Sigma, St.
Louis, MO) gels in 0.5x TBE buffer (BioRad) after staining with ethidium bromide. Image
analysis was done using the Quantity One imaging software (BioRad). Total community DNA
was purified using a Prep-A-Gene purification kit (BioRad), according to the manufacturer’s
instructions.
3.2.3. Amplification of 16S rRNA Genes From Bacterial Community DNA
In order to amplify the 16S rRNA genes of the bacterial community in each sample,
PCR reactions were performed on total community DNA using the universal eubacterial
primers: 27f (5’-GAG TTT GAT CCT GGC TCA G-3’) and 1525r (5’-AGA AAG GAG GTG
ATC CAG CC-3’) (Rainey, F.A., et al, 1996). These primers bind to highly conserved
sequences of the bacterial 16S rRNA gene (Brosius, J., et al, 1978) and produce amplicons of
1.5 kb. Amplification of the 16S rRNA genes was done using Taq polymerase. PCR reactions
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were carried out with a Perkin Elmer PCR system 2400 thermocycler (Applied Biosystems,
Foster City, CA). Briefly, 6 min. of a hot start step at 98oC were followed by 35 cycles with 30
sec. denaturing at 94oC, 30 sec. primer annealing at 52oC and 60 sec. elongation at 72oC; then a
final elongation step of 7 min. at 72oC. PCR products were checked by agarose gel
electrophoresis using 2% agarose I in 0.5x TBE buffer (BioRad) and staining with ethidium
bromide.
3.2.4. 16S rRNA Gene Library
In order to construct a library containing representative clones of the 16S rRNA genes
of all the bacteria present in each sample (Ward, D.M., et al, 1998; Hengstmann, U., et al,
1999; Amann, R. and Ludwig, W., 2000), the amplification products obtained with the
universal eubacterial primers were ligated into pCR 2.1-TOPO (Invitrogen, Carlsbad, CA)
using the TOPO-TA cloning kit (Invitrogen), as indicated by the manufacturer. Recombinant
plasmids were transformed into chemically competent TOP10 Escherichia coli cells
(Invitrogen) and transformants were selected using Luria-Bertani (LB) (Sambrook, J., et al,
1989) plates supplemented with 50 µg/ml kanamycin (KAN), as recommended by the
manufacturer. Transformants that grew on LB-KAN plates were picked and grown in LB-KAN
media for plasmid isolation.
3.2.5. Amplification of 16S rRNA Genes
To screen for clones with appropriate insert size, DNA inserts from each of these clones
were amplified using M13 universal primers (5’- GTA AAA CGA CGG CCA G – 3’ and 5’CAG GAA ACA GCT ATG AC– 3’). Amplification of the 16S rRNA genes was done using
Taq polymerase. PCR reactions were carried out using a Perkin Elmer PCR system 2400
thermocycler, with an initial heating step of 3 min. at 94oC, followed by 25 cycles with 30 sec.
denaturing at 94oC, 30 sec. primer annealing at 52oC and 60 sec. elongation at 72oC; then a
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final elongation step of 9 min. at 72oC. PCR products were separated on 2% agarose I gels,
using the 100 bp DNA ladder (Invitrogen) as molecular standards, and visualized after staining
with ethidium bromide.
3.2.6. ARDRA
16S rRNA PCR products were digested using Taq1 for 1 h. at 65°C. Restriction
fragments were separated in 3.0% GenepureSieve GQA agarose gels (ISC BioExpress) in TBE
(BioRad). Agarose gels were tempered at 55-60ºC for 25 min. before pouring, then cooled for
30 min. at room temperature and 30 min. at 5oC, before use. Different restriction fragments
were analyzed by comparison to DNA Molecular Weight Marker VIII (Roche Diagnostics,
Basel, Switzerland) using the Bionumerics ARDRA software (Applied Maths, St.-MartensLatem, Belgium).
3.2.7. Partial Sequencing of Selected Clones
Recombinant plasmids with appropriate sized inserts (1.5 kb) were purified from
transformant E. coli to use for sequencing, using QIAprep Spin columns (Qiagen, Valencia,
CA) as recommended by the manufacturer. Clones were sequenced using the 27f primer.
Automated sequencing was done with fluorescent dye-labeled dideoxynucleotides using an
ABI PRISM 310 Genetic Analyzer (Applied Biosystems).
3.2.8. 16S rRNA Gene Sequence Analysis
The sequence data obtained from the cloned 16S rRNA inserts was used to search
existing databases for similar 16S rRNA gene sequences, using the Ribosomal Database Project
(available through http://rdp.cme.msu.edu/) (Maidak, B.L., et al, 2000; Maidak, B.L., et al,
2001) and BLAST (Altschul, S.F., et al, 1997) (National Center for Biotechnology Information,
available through http://www.ncbi.nlm.nih.gov/BLAST/). Sequence alignment and editing was
done using VectorNTI (Invitrogen) and BioEdit (version 7.0.5.2) (Hall, T.A., 1999).
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Phylogenetic and molecular evolutionary analyses were performed using the MEGA software,
version 3.1 (Kumar, S., et al, 2004). Phylogenetic trees were generated using the neighborjoining method (Saitou, N. and Nei, M., 1987) and evolutionary distance matrices were
calculated using the Jukes-Cantor algorithm (Jukes, T.H. and Cantor, C., 1969).
3.3 Results and Discussion
Five 16S rRNA gene libraries were constructed from the GEN dip solutions recovered
at the turtle farms in June 2002, in Louisiana. Figure 3.1 shows some of the PCR products
obtained from the amplification of cloned 16S rRNA genes. Approximately 550 clones were
screened for the appropriate insert size of 1.5 kb; around 300 of these had the correct insert size
and were thus selected for further identification analysis. ARDRA analysis was used as a
guideline to select representative clones to sequence and revealed different Taq1 restriction
digestion patterns, as illustrated in Figure 3.2.
Sequences obtained from partial sequencing of the cloned 16S rRNA inserts lead to the
identification of both culturable and uncultured organisms from the samples studied. Organisms
(and accession numbers of the closest nucleotide sequence hits obtained through BLAST)
identified by partial sequencing of the cloned 16S rRNA genes are summarized in Table 3.1.
To perform phylogenetic and molecular evolutionary analyses, sequences were aligned
and edited using VectorNTI (Invitrogen) and BioEdit (Hall, T.A., 1999), as described above.
For this, a representative clone was selected from each group of identical sequences and
designated as an operational taxonomic unit (OTU) (Table 1). Sequence data corresponding
approximately to bases numbers 100 to 500 (E. coli numbering) (Brosius, J., et al, 1978) was
used to generate phylogenetic trees and distance matrices as presented in Figure 3.3. In this
study we found a more diverse group of organisms to survive GEN treatment than
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Figure. 3.1. Selection of Appropriate Clones by M13 Amplification of
Cloned 16S rRNA Gene Inserts. Lanes 1-21 (gels A and B) show M13 PCR
products obtained from different clones. 100 bp DNA ladder (Invitrogen) was
used as molecular size standard (M). Clones with an appropriate size insert of
1.5 kb were further analyzed. Clones from gel A, lanes 4, 5, 18, 19, 21, and
gel B, lanes 2, 5, 6, 7, 17, 20, were excluded from the study due to their
improper size.
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Figure. 3.2: ARDRA. Lanes 2-12 & 14-23 show some of the restriction digests of the
16S rRNA PCR products obtained using restriction enzyme Taq1. Five different
restriction patterns are evident: A (lanes 1, 11, 16, 19), B (lanes 2, 3, 5, 6, 12), C (lanes 4,
7, 10, 14, 15, 20-23), D (lane 8), and E (lanes 17, 18). M: DNA Molecular Weight
Marker VIII (Roche Diagnostics)
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Table 3.1. Organisms Identified by Partial Sequencing of 16S rRNA Genes
Organism

Accession

% ID

N1

OTU2

Alcaligenes sp.

AJ002804

99

14

clone JVB3

Alcaligenes xylosoxidans

AJ551119

99

10

clone JVB4

Biocide-degrading bacterium 111

AY941083

100

10

clone JVB5

Burkholderia sp. SE-10

AY568514

100

6

clone JVA2

Collimonas sp. CTO 113

AY281151

99

16

clone JVB2

Comamonas sp. JS46

AY819705

99

8

clone PPA3

Comamonas testosteroni

AY653219

99

84

clone JVA1

Comamonas testosteroni MBIC3841

AB007997

99

10

clone PPB1

Delftia tsuruhatensis strain ARI_5

AY684785

99

6

clone PPA4

Flexibacter group bacterium LA48

AF513436

89

12

clone JVA6

Methylophilus methylotrophus

AB193724

99

34

clone PPB2

Ochrobactrum aqua-oryzae strain MTCC
4195T.

AM041247

100

2

clone JVA7

Pseudomonas putida strain P19

AY972175

99

16

clone PPA1

Pseudomonas sp. 48XA

DQ103513

100

18

clone JVB1

Pseudomonas sp. WT OTU2

AY965247

99

4

clone PPA2

Uncultured bacterium clone LS27

AY559425

99

2

clone JVB6

Uncultured bacterium clone Tc65

AF445125

95

2

clone JVA5

Uncultured bacterium clone TM09 16S

AY838517

99

8

clone PPA5

Uncultured bacterium DSSD57

AY328755

99

28

clone PPB3

AY133096

98

4

clone PPC1

AY360633

97

2

clone JVA4

AF285414

99

2

clone JVA3

Uncultured beta proteobacterium clone
ccslm36
Uncultured Planctomycetales bacterium
clone M10Ba43
Xenophilus azovorans
1

Total number of clones with indicated sequence identities. 2 Operational Taxonomic
Units (OTUs) used to construct phylogenetic trees
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Figure 3.3. Phylogenetic Tree of Organisms Identified in This Study
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originally anticipated. In fact, using a culture-dependent approach we had only identified
Alcaligenes spp. and Pseudomonas spp. of the organisms listed in Table 3.1. (Diaz, M.A., et al,
in press). In effect, the assessment of microbial diversity is largely underestimated by classic
culture methods (Ward, D.M., et al, 1998; Hengstmann, U., et al, 1999). In conventional
culturing methods, specific growth conditions favor the growth of bacteria that are better
adapted to the given culture conditions, which do not necessarily reflect the natural
environment. Consequently, microorganisms identified by these methods do not illustrate the
microbial community significantly (Ward, D.M., et al, 1998; Hengstmann, U., et al, 1999;
Amann, R. and Ludwig, W., 2000). In fact, the fraction of microbial diversity which has been
obtained from culture methods has been estimated to be less than one per cent of the total
microbial diversity (Amann, R.I., et al, 1995; Amann, R. and Ludwig, W., 2000).
Table 3.2 summarizes the percentages of organisms identified in each sample. All
species found with the studies performed had been previously reported. On the other hand,
previously reported uncultured bacteria were identified in all of the samples tested. In effect,
these previously reported uncultured bacteria had been detected in environmental samples.
Though it is not possible to infer an ecological role or phenotype for the organisms identified
based on the phylogenetic position of their 16S rRNA gene sequence, the information provided
should prove useful as a qualitative tool for the study of these bacterial communities (Ward,
D.M., et al, 1998; Hengstmann, U., et al, 1999). Furthermore, this type of study could aid in the
detection of possible antibiotic producers or other organisms which help maintain the antibiotic
resistance pool and yet are missed by classical bacteriological drug-resistance testing.
The most common genera encountered in the GEN treatment solutions were
Comamonas spp. (34%), Pseudomonas spp. (12%), and Methylophilus spp. (11%) as can be
seen in Table 3.2. Comamonas spp. was found in every location studied. It is important to
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mention, though, that the culture-independent approach to the identification of bacteria in a
community, based on 16S rRNA gene sequencing, is known to have important limitations as a
quantitative tool (Rainey, F.A., et al, 1996; Hengstmann, U., et al, 1999). One such limitation
is the bias obtained from the proportions of the 16S rRNA sequence types that are recovered
(Hengstmann, U., et al, 1999). In addition, it is also not possible with the present approach to
determine the resistance mechanisms which allow the identified non-culturable bacteria to
survive such high levels of GEN. However, in a previous study, we found two genes which are
carried by bacteria recovered from environmental samples with turtle farming activity, which
exhibit high-level GEN resistance (Diaz, M.A., et al, in press). These are aac(3)IIa and
aac(3)VIa, which code for aminoglycoside acetyl-transferase enzymes. Only gene aac(3)IIa
was detected in pseudomonads and other non-fermentor Gram-negative bacilli in the studies
performed (Diaz, M.A., et al, in press). We do not discard the possibility of the dissemination
of these genes amongst some of the organisms detected in this study. Other resistance
mechanisms often observed in the identified bacteria include adaptive resistance and reduced
uptake of the antibiotic (Karlowsky, J.A., et al, 1996; Putman, M., et al, 2000). In addition,
recent studies performed elsewhere have reported plasmid-mediated genes which confer highlevel aminoglycoside resistance in Klebsiella pneumoniae (Galimand, M., et al, 2003),
Pseudomonas aeruginosa (Yokoyama, K., et al, 2003) Serratia marcescens (Doi, Y., et al,
2004) and other microorganisms (Yamane, K., et al, 2005). Further studies would be needed to
determine the resistance mechanisms which allow these bacteria to survive such high-levels of
GEN.
In this study, we used a culture-independent approach for the identification of bacteria
that can survive or thrive in GEN treatment solutions as it provides a less biased technique for
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Table 3.2. Most Prevalent Genera Identified by Partial Sequencing of 16S rRNA Genes in GEN
Treatment Solutions From Five Different Locations in Louisiana in June, 2002.

Organism

Comamonas spp.

JVA

JVB

Sample Site
PPA

(n=60)

(n=76)

(n=56)

(n=76)

(n=30)

% (N)

63.3 (38)

7.9 (6)

39.3 (22)

13.2 (10)

86.7 (26)

34 (102)

23.7 (18)

35.7 (20)

Pseudomonas spp.
Methylophilus spp.

PPB

PPC

Total

13 (38)
44.7 (34)

11 (34)

Alcaligenes spp.

31.6 (24)

8 (24)

Collimonas spp.

21.1 (16)

5 (16)

Flexibacter spp.

20.0 (12)

4 (12)

other

10.0 (6)

13.2 (10)

10.7 (6)

5.3 (4)

Uncultured bacteria clones

6.7 (4)

2.6 (2)

14.3 (8)

36.8 (28)

89

9 (26)
13.3 (4)

15 (46)

the qualitative study of bacterial communities (Ward, D.M., et al, 1998; Hengstmann, U., et al,
1999; Amann, R. and Ludwig, W., 2000; Heuer, H., et al, 2002). With this approach, we
identified bacteria that are able to survive high concentrations of GEN (1000 µg/ml) for one
year at 4oC, which are the conditions at which the antibiotic baths are stored, and may possibly
serve as antibiotic resistance reservoirs but yet would escape detection by classic antibiotic
resistance monitoring.
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CHAPTER 4:
INTEGRONS AND GENE CASSETTES IN BACTERIA FROM
THE TURTLE FARM ENVIRONMENT
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4.1 Introduction
Gentamicin is an antibiotic which belongs to the family of the aminoglycosides, which
are broad-spectrum antibiotics commonly used in combination with β-lactams for the treatment
of aerobic Gram-negative infections (Miller, G.H., et al, 1997; Vakulenko, S.B. and
Mobashery, S., 2003). In recent studies, bacteria which were highly resistant to gentamicin
were recovered from various sources on commercial turtle farms in Louisiana (D'Aoust, J.Y., et
al, 1990; Diaz, M.A., et al, 2000). This lead to investigation into resistance determinants as
well as the molecular environment of the resistance genes identified (Diaz, M.A., et al, 2001;
Diaz, M.A., et al, 2002b; Diaz, M.A., et al, 2002a). Plasmid-encoded aminoglycoside
acetyltransferase genes aac(3)IIa and aac(3)VIa were found to be the most prevalent in
gentamicin resistant bacteria recovered from turtle farms (Diaz, M.A., et al, 2000; Diaz, M.A.,
et al, in press). Furthermore, the gene aac(3)VIa was found within a class 1 integron (Stokes,
H.W. and Hall, R.M., 1989; Diaz, M.A., et al, 2001; Diaz, M.A., et al, 2002b).
Integrons, which were first described by Stokes and Hall in 1989, are gene-capture
molecular elements that contain an integrase gene, intI, and an arrangement of gene cassettes
which are expressed from a common promoter, Pant (Stokes, H.W. and Hall, R.M., 1989; Collis,
C.M., et al, 1998; Ploy, M.C., et al, 2000). These molecular elements have since been detected
on plasmids and in the chromosomes of Gram-negative bacteria (Hall, R.M. and Stokes, H.W.,
1993; Fluit, A.C. and Schmitz, F.J., 1999). Class-1 integrons, the most prevalent among clinical
isolates (Fluit, A.C. and Schmitz, F.J., 1999; White, P.A., et al, 2001; Fluit, A.C. and Schmitz,
F.J., 2004), are characterized by two conserved regions (5’-CS and 3’-CS) flanking a variable
region (Hall, R.M. and Collis, C.M., 1995). The 5' conserved region includes the integrase gene
intI1 and a gene cassette attachment site, attI (Collis, C.M., et al, 1993; Hall, R.M. and Collis,
C.M., 1995; Partridge, S.R., et al, 2000). The 3' conserved region is characterized by the
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presence of a quaternary ammonium compound resistance gene, qacE∆1, a sulfonamide
resistance gene, sul1, and two open reading frames with unknown functions: orf5 and orf6
(Stokes, H.W. and Hall, R.M., 1989; Hall, R.M., et al, 1994). The variable region of class-1
integrons can include one or more gene cassettes (Stokes, H.W. and Hall, R.M., 1989; Hall,
R.M. and Stokes, H.W., 1993).
The majority of gene cassettes described to date code for antibiotic resistance (Fluit,
A.C. and Schmitz, F.J., 1999; Fluit, A.C. and Schmitz, F.J., 2004) and are thus known as
multiple resistance integrons, or MRIs (Recchia, G.D. and Hall, R.M., 1995; Fluit, A.C. and
Schmitz, F.J., 1999; Mazel, D. and Davies, J., 1999). There is a larger type of integron, referred
to as “super-integrons”, or SIs, which was originally described in Vibrio cholerae (Mazel, D.,
et al, 1998; Rowe-Magnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D., 1999; Clark,
C.A., et al, 2000). SIs have later been found as components of the genomes of many γproteobacteria, such as Xanthomonas spp., Shewanella spp. and Pseudomonas spp. (RoweMagnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D., 1999; Vaisvila, R., et al, 2001).
In order to provide Salmonella-free pet turtles to the export market, the Louisiana pet
turtle industry treats turtle eggs with gentamicin sulfate (Garasol; Shering Corp., Bloomfield,
N.J.) at 1000 ppm (µg/ml) (Siebeling, R.J., et al, 1975; Michael-Marler, S., et al, 1983;
Siebeling, R.J., et al, 1984), using a pressure-differential gentamicin egg-dip procedure adapted
from the turkey industry (Saif, Y.M. and Shelly, S.M., 1973; Greenfield, J., et al, 1975;
Ekperigin, H.E., et al, 1983). In previous studies, we detected gene aac(3)VIa as a gene cassette
in gentamicin resistant isolates from turtle farms as well as some integron-associated elements
in isolates carrying aac(3)IIa (Diaz, M.A., et al, 2000; Galimand, M., et al, 2003; Galimand,
M., et al, 2005; Diaz, M.A., et al, in press).
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The goal of the present study was to characterize the class-1 integrons in gentamicin
resistant isolates recovered from pet turtle farms and to investigate any genes which may be coselected in the presence of gentamicin.
4.2 Materials and Methods
4.2.1. Bacterial Strains and Plasmids Used in This Study
Bacterial strains used in this study were isolated previously (Diaz, M.A., et al, in press)
from environmental samples with turtle farming activity and are summarized in Table 4.1.
Gram-negative bacteria were routinely grown at 37oC using McConkey (Difco, Detroit, MI)
plates. Laboratory strains were grown using Luria-Bertani (LB) media (Sambrook, J., et al,
1989). All GEN-resistant strains were propagated in media supplemented with 100 µg/ml GEN.
A summary of all laboratory bacterial strains and plasmids used in this study is found in Table
4.1.
4.2.2. Antibiotic Susceptibility Assays
The Kirby-Bauer disk-diffusion assay was done using MH agar plates according to
NCCLS standards (NCCLS, 1999) using the following antibiotics: GEN (10 µg), KAN (30 µg),
TOB (10 µg), AMK (30 µg), ampicillin (AMP) (10 µg), tetracycline (TET) (30 µg),
chloramphenicol (CHL) (30 µg), polymixin B (PMB) (300 units), cephalothin (CEF) (30 µg),
cefotaxime (CTX) (30 µg), trimethoprim (TMP) (5 µg), and nitrofurantoin (NIT) (300 µg)
(Difco). Inhibition zone breakpoints were interpreted according to information supplied by the
manufacturer and to NCCLS standards (NCCLS, 1999).
4.2.3. Screening for Genes Associated with Class-1 Integrons by PCR
In order to screen for the presence of putative integrases and gene cassettes which could
contribute to the spread and increased level of gentamicin resistance, we screened for putative
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Table 4.1. Bacterial Strains and Plasmids Used in This Study
Strain or plasmid

Relevant characteristics

Source or Reference

Bacterial strains
E. coli TOP10

Electrocompetent or chemically competent.
F- mcrA ∆(mrr-hsdRMS-mcrBC)
Ф80lacZ∆M15 ∆lacX74 recA1 deoR araD139
(ara-leu)7697 galU galK rpsL
(Strr) endA1 nupG GENs (MIC: <3.9 µg/ml)

Pseudomonas aeruginosa
strain PS7

GEN MIC: >2000 µg/ml

(12)

Stenotrophomonas maltophilia
strain St16

GEN MIC: >2000 µg/ml

(12)

Salmonella enterica subsp.
enterica strain S5

GEN KAN TOB; GEN MIC: >2000 µg/ml

(12)

Salmonella enterica subsp.
arizonae strain PH5

GEN KAN TOB; GEN MIC: >2000 µg/ml

(12)

Enterobacter cloacae strain E19

GEN KAN TOB; GEN MIC: >2000 µg/ml

(12)

Citrobacter freundii strain C14

GEN KAN TOB; GEN MIC: >2000 µg/ml

(12)

Invitrogen

(table cont’d)
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Plasmids
pCR2.1-TOPO

cloning and sequencing vector; KAN

Invitrogen

pCSt16

pCR2.1-TOPO derivative with 1 kb insert from
5’CS-3’CS PCR obtained from
Stenotrophomonas maltophilia strain St16

this study

pCSeS5

pCR2.1-TOPO derivative with 1 kb insert from
5’CS-3’CS PCR obtained from Salmonella
enterica subsp. enterica strain S5

this study

pCSaPH5

pCR2.1-TOPO derivative with 1 kb insert from
5’CS-3’CS PCR obtained from Salmonella
enterica subsp. arizonae strain PH5

this study

pCEcE19

pCR2.1-TOPO derivative with 1 kb insert from
5’CS-3’CS PCR obtained from Enterobacter
cloacae strain E19

this study

pCCfC14

pCR2.1-TOPO derivative with 1 kb insert from
5’CS-3’CS PCR obtained from Citrobacter
freundii strain C14

this study

pCPaPs7

pCR2.1-TOPO derivative with 2.5 kb insert
from 5’CS-3’CS PCR obtained from
Pseudomonas aeruginosa strain Ps7

this study
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integrase genes and gene cassettes in the turtle pond environment using degenerate primers
previously published (Nield, B.S., et al, 2001; Stokes, H.W., et al, 2001). Degenerate primers
used to detect these putative genes and PCR conditions are summarized in Table 4.2. Different
size PCR products were purified from agarose gels using QIAquick Spin kits (Qiagen,
Valencia, CA) and cloned using Invitrogen’s TOPO-TA cloning kit (Invitrogen, Carlsbad, CA),
as recommended by the manufacturer. Recombinant plasmids were transformed into
chemically competent TOP10 Escherichia coli cells (Invitrogen), and transformants were
selected on LB-KAN plates (50 µg/ml). DNA inserts from these clones were amplified using
the M13 universal primers.
In addition, PCR assays were designed to screen environmental isolates for genes
commonly associated with class 1 integrons, using primers published elsewhere (Levesque, C.,
et al, 1995; Schwocho, L.R., et al, 1995; Sandvang, D., et al, 1997; Galimand, M., et al, 2003)
and summarized in Table 4.2. PCR screening of genes intI, sul1 (Stokes, H.W. and Hall, R.M.,
1989; Schwocho, L.R., et al, 1995), and of armA, reported to confer high-level aminoglycoside
resistance in Gram-negative bacteria and to be associated with complex class-1 integrons
(Galimand, M., et al, 2003; Galimand, M., et al, 2005), was done in separate reactions. PCR
assays were also performed to detect complex integron-associated orf513, coding a putative
recombinase. Other primer sets used to amplify these integron regions include: 1) 5'CS and
3'CS; 2) 5'CS and orf513-R and 3) orf513-F and sulR.
To prepare DNA for PCR, pelleted cells from 1 ml of overnight cultures were
resuspended in 100 µl dH2O and lysed through two 5 min. freeze-boil cycles. Two µl of the
supernatants were used as templates in 50 µl PCR reactions. PCR was done using the
FailSafe™ PCR System, buffer “G”, or buffer “F” (Epicentre Biotechnologies, Madison, WI),
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Table 4.2. Primers Used for PCR and Sequencing
Amplicon
Sequence (5' → 3')
size (bp)

Accession No.
(Reference)

PCR target

Primer

intI1

intIF
intIR

845

CTA CCT CTC ACT AGT GAG GGG CGG
GGG CAG CAG CGA AGT CGA GGC

X15852 (44, 47)

intI1

int1F
int1R

568

ACA TGT GAT GGC GAC GCA CGA
ATT TCT GTC CTG GCT GGC GA

M95287 (17, 47)

intI1, intI2, intI3

hep35
hep36

491

TGC GGG TYA ARG ATB TKG ATT T
CAR CAC ATG CGT RTA RAT

(54)

cassette array

hep74
hep51

variable

CGG GAT CCC GGA CGG CAT GCA CGA TTT GTA
GAT GCC ATC GCA AGT ACG AG

(54)

intIN / array

HS286
HS287
HS298

variable

GGG ATC CTC SGC TKG ARC GAM TTG TTA GVC
GGG ATC CGC SGC TKA NCT CVR RCG TTA GSC
TGG ATC CCA CRT GNG TRT ADA TCA TNG T

(30, 48)

cassette array

5’CS
3’CS

variable

GGC ATC CAA GCA GCA AGC
AAG CAG ACT TGA CCT GAT

orf513

orf513F
orf513R

aac(3)II

aac3F
aac3R

aac(3)-IIa

M73819 (24)

CTC GCT ACA TCC AAC AAG AA
TGT CAC GCC AGT TAG TAT CG

(31)

860

ATG CAT ACG CGG AAG GCA AT
CTA ACC TGA AGG CTC GCA A

L22613 (17)

aacIIaF
aacIIaR

900

GGG AAT TCA GAG GAG ATA TCG CGA TGC ATA CG
CAT TGT CGA CGG CCT CTA ACC

X13543 (12)

aac(3)-VIa

aacVIaF
aacVIaR

465

CGC TCA GGC GAT ATG GTG AT
CAT AAT GGA GCG CGG TGA CT

L22613 (12)

sul1

sulF1
sulR

840

ATG GTG ACG GTG TTC GGC AT
CTA GGC ATG ATC TAA CCC TC

U12441 (17, 47)

M13F (-20)
M13R

variable

GTA AAA CGA CGG CCA G
CAG GAA ACA GCT ATG AC
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(Invitrogen)

according to instructions provided by the manufacturer. Thermocycler conditions were set as
follows: [1X (96oC, 5 min); 35X (96oC, 30 sec; 55oC, 30 sec; 70oC, 60 sec); (70oC, 7 min)].
PCR products were visualized by agarose gel electrophoresis using 2% Agarose I in 0.5x TBE
buffer and staining with ethidium bromide. Some of the PCR products obtained were
sequenced in order to confirm amplification of the appropriate genes and to compare with
published sequences in the databases. For this, PCR products were purified using QIAquick
Spin columns (Qiagen) and ligated into pCR2.1-TOPO using the TOPO-TA cloning kit
(Invitrogen), as indicated by the manufacturer. Sequencing of appropriate clones was done
using the internal vector sequencing primers, as described above.
4.2.4. Sequencing and Computer Analysis
Sequencing was done using the M13 universal primers with fluorescent dye-labeled
dideoxynucleotides with an ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster
City, CA). Sequence analysis was done using VectorNTI (Invitrogen), BLAST (2) and
GeneBank

(National

Center

for

Biotechnology

Information,

available

through

http://www.ncbi.nlm.nih.gov/BLAST/).
4.3 Results
The goal of this study was to search for integron classes carrying gentamicin resistance
genes which could also contribute to the co-selection of other resistance genes under
gentamicin selective pressure. PCR amplification of gene intI1 using primers intIF and intIR
(Schwocho, L.R., et al, 1995) allowed the detection of class 1 integrase in E. coli-pAriPH5, E.
coli-pEntE19, but not in Pseudomonas aeruginosa, Stenotrophomonas maltophilia, or E. colipSalS5 (Figure 4.1). Since aac(3)IIa was encoded in the latter organisms, and this gene was
reported to be associated with gene armA, as well as orf513, and intI1 (Galimand, M., et al,
2003; Galimand, M., et al, 2005), these genes were screened for with the primers published by
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Figure 4.1. PCR Amplification Products of intI1 Gene.
PCR reaction was carried out using intIF and intIR primers.
Lane 1, Ps. aeruginosa; lane 2, E. coli-pSalS5; lane 3, E. colipAriPH5; lane 4, E. coli-pEntE1; lane M, 100 bp molecular
size marker.
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these researchers (Galimand, M., et al, 2003; Partridge, S.R. and Hall, R.M., 2003). Gene armA
was not detected in any of the isolates assayed in this study (Chapter 2). In addition, screening
for complex-integron associated orf513 has not been detected in the isolates tested thus far.
However, when screening for integrase class 1 with this primer set, it was possible to detect
intI1 in isolates carrying aac(3)IIa, as well as those carrying aac(3)VIa. Figure 4.2 summarizes
these findings.
Primers hep35 and hep36 anneal to conserved regions of integrase genes intI1, intI2,
and intI3 (White, P.A., et al, 2001). Primers hep74 and hep51 were designed to amplify class 2
integron cassette regions by annealing to attI2 and to orfX, which is downstream of the cassette
region within Tn7 (White, P.A., et al, 2001). Moreover, primers HS286, HS287 and HS298
have been used to detect integrase genes and cassettes from environmental DNA with success
(Nield, B.S., et al, 2001; Stokes, H.W., et al, 2001). Numerous amplicons with appropriate
sizes (greater than 1 kb) were obtained from over 200 isolates tested, and cloned into pCR2.1TOPO using the TOPO-TA cloning kit, but sequencing of these clones did not lead to the
detection of integrase genes other than intI1.
PCR performed using primer set 5’CS and 3’CS (Levesque, C., et al, 1995) produced
amplicons with sizes which could include gene cassettes. Interestingly, different sizes of
amplicons were obtained from isolates which are known to carry the same gene (Figure 4.3).
Preliminary sequencing has confirmed that these are in fact integron elements, or cassettes
(data not shown). Sequencing of these clones is currently underway.
4.4 Discussion
The goal of the present study was to characterize the integrons in gentamicin resistant
isolates recovered from the pet turtle farm environment, since these molecular elements can
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Figure 4.2. PCR Amplification Products of Integron-Associated
Genes intI1, aac(3)IIa, and aac(3)VIa. Lanes 1 and 5, amplification
of aac(3)II using primers aacIIF and aacIIR (Galimand, M., et al,
2003); lanes 2 and 6, multiplex PCR amplification of genes aac(3)IIa
and aac(3)VIa using primers aacIIaF, aacIIaR, aacVIaF and aacVIaR
(Vliegenthart, J.S., et al, 1990; E.C. Achberger, personal
communication); lanes 3 and 7, amplification of intI1 using primers
int1F and int1R (Galimand, M., et al, 2003); lanes 4 and 8,
amplification of intI1 using primers intIF and intIR (Schwocho, L.R.,
et al, 1995); lanes M, 100 bp molecular size marker.
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Figure 4.3. PCR Amplification Products of 5’CS3’CS Primers. Lane 1, Pseudomonas aeruginosa strain
Ps7; lane 2, Stenotrophomonas maltophilia strain St16;
lane 3, Salmonella enterica subsp. enterica strain S5;
lane 4, Salmonella enterica subsp. arizonae strain PH5;
lane 5, Enterobacter cloacae strain E19; lane 6,
Citrobacter freundii strain C14.
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contribute not only to the spread of gentamicin resistance but also to that of other resistance
genes of public health importance, which may be co-selected in the presence of gentamicin.
Four different classes of integrons had been identified before 2001, encoding different
integrase genes and overall gene arrangements; these were integrons class-1 (Stokes, H.W. and
Hall, R.M., 1989), class-2, class-3 (Collis, C.M., et al, 2002) and class-4 (Mazel, D., et al,
1998). In a previous study, we had detected the presence of the gene aac(3)VIa associated with
the integron class-1 integrase gene. However, isolates carrying aac(3)IIa had been considered
intI1- negative when assayed with the primer set described (Schwocho, L.R., et al, 1995; Diaz,
M.A., et al, in press), which was consistent with reports at the time (Brau, B., et al, 1984;
Allmansberger, R., et al, 1985; Rather, P.N., et al, 1992; Rather, P.N., et al, 1993; Diaz, M.A.,
et al, 2000; Diaz, M.A., et al, 2001). On the other hand, we had detected the presence of
aac(3)IIa in different plasmids and diverse bacterial genera of organism, so we hypothesized
that the gene was encoded within a mobile molecular element, such as another integron besides
class-1, possibly a superintegron as described in Xanthomonas spp., Shewanella spp., and
Pseudomonas spp. (Rowe-Magnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D.,
1999; Vaisvila, R., et al, 2001). For this reason we screened for the presence of putative
integrase (Nield, B.S., et al, 2001) and gene cassette genes (Stokes, H.W., et al, 2001), using
degenerate primers designed elsewhere to detect these elements from environmental DNA.
None of the PCR amplicons obtained with these primers rendered any gene which could be
associated to an integron element, other than the ones already identified (Diaz, M.A., et al,
2002b; Diaz, M.A., et al, 2002a).
Preliminary sequencing of the different integron molecular environments in this study
did not lead to the detection of any mutation which could have an effect on the expression of
the gentamicin resistance gene cassettes. Gene aac(3)VIa was found to be in the first position in
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the gene cassette array, near the integrase gene. On the other hand, even though we did not
detect intI1 gene associated with the gene aac(3)IIa in our preliminary work, we did detect
other integron elements in bacteria carrying this gene (Diaz, M.A., et al, 2002b; Diaz, M.A., et
al, 2002a). Interestingly, recent studies have also depicted the aac(3)IIa gene to be surrounded
by integron elements (Galimand, M., et al, 2003; Galimand, M., et al, 2005). In fact, the
molecular environment of the armA gene has been depicted as a composite integron
environment, characterized by the presence of a 5’-CS and a 3’-CS interspanning a variable
region which includes a sul1 gene and a gene known as orf513 (Partridge, S.R. and Hall, R.M.,
2003; Galimand, M., et al, 2005). This same type of arrangement has later been described in
other organisms and it is thought to involve a mobile integrative structure known as a
conjugative transposon (Salyers, A.A., et al, 1995; Partridge, S.R. and Hall, R.M., 2003). The
latter are DNA elements that can excise themselves to form a covalently closed circular
intermediate (Salyers, A.A., et al, 1995); this intermediate can reintegrate itself within the same
organism or, it can be transfered by conjugation to a recipient cell and then integrate in the
recipient’s genome (Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and
Hall, R.M., 2003). These integrative molecular elements were first found in Gram-positive
bacteria such as the streptococci and enterococci (Tolmasky, M.E., 2000) and were barely
mentioned before 1996 in connection with Gram-negative bacteria (Pembroke, J.T., et al,
2002). Conjugative transposon-like elements have later been detected in Gram-negative
bacteria such as Bacteroides spp. (Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002) and
though characterized in a lesser extent, in the Enterobacteriaceae. They have been reported in
Salmonella spp., Proteus spp., in the R391 element and in the SXT element in Vibrio spp.
(Salyers, A.A., et al, 1995; Beaber, J.W., et al, 2002; Pembroke, J.T., et al, 2002; Partridge,
S.R. and Hall, R.M., 2003).

108

The variable region of class-1 integrons can code for one or more gene cassettes
(Stokes, H.W. and Hall, R.M., 1989; Hall, R.M. and Stokes, H.W., 1993). In this study, we
used published conserved sequence primers (Levesque, C., et al, 1995; Sandvang, D., et al,
1997) to screen for the presence of different gene arrays in the isolates under study.
Interestingly, this not only lead to the detection of the expected gene cassette amplicons from
organisms known to be carrying gene aac(3)VIa within a class-1 integron, but we also obtained
amplicons for organisms which carried gene aac(3)IIa and which were recently detected to
carry intI1. Therefore, it is possible that gene aac(3)IIa is carried by a complex integron and
thus was not detected as such with the primer pair used to detect the classic structure of
integron class-1 (Galimand, M., et al, 2003). Sequencing of amplicons obtained with 5’CS3’CS primers will shed light in this regard (Levesque, C., et al, 1995; Sunde, M. and Sorum,
H., 1999). Transfer of aac(3)IIa may involve a complex integron class-1. The presence of
aac(3)IIa and aac(3)VIa in mobile molecular elements explains the distribution of these genes
in the different bacterial genera described in this study (Holmes, A.J., et al, 2003). Further
studies of their molecular environment are required in order to detect and characterize these
mobile molecular elements, and to detect genes which may be co-selected in the presence of
gentamicin.
4.5 References
1.

Allmansberger, R., B. Brau, and W. Piepersberg. 1985. Genes for gentamicin-(3)-Nacetyl-transferases III and IV. II. Nucleotide sequences of three AAC(3)-III genes and
evolutionary aspects. Mol. Gen. Genet. 198:514-520.

2.

Beaber, J. W., B. Hochhut, and M. K. Waldor. 2002. Genomic and functional
analyses of SXT, an integrating antibiotic resistance gene transfer element derived from
Vibrio cholerae. J. Bacteriol. 184:4259-4269.

3.

Brau, B., U. Pilz, and W. Piepersberg. 1984. Genes for gentamicin-(3)-Nacetyltransferases III and IV: I. Nucleotide sequence of the AAC(3)-IV gene and

109

possible involvement of an IS140 element in its expression. Mol. Gen. Genet. 193:179187.
4.

Clark, C. A., L. Purins, P. Kaewrakon, T. Focareta, and P. A. Manning. 2000. The
Vibrio cholerae O1 chromosomal integron. Microbiology 146 ( Pt 10):2605-2612.

5.

Collis, C. M., G. Grammaticopoulos, J. Briton, H. W. Stokes, and R. M. Hall. 1993.
Site-specific insertion of gene cassettes into integrons. Mol. Microbiol. 9:41-52.

6.

Collis, C. M., M. J. Kim, S. R. Partridge, H. W. Stokes, and R. M. Hall. 2002.
Characterization of the class 3 integron and the site-specific recombination system it
determines. J. Bacteriol. 184:3017-3026.

7.

Collis, C. M., M. J. Kim, H. W. Stokes, and R. M. Hall. 1998. Binding of the purified
integron DNA integrase Intl1 to integron- and cassette-associated recombination sites.
Mol. Microbiol. 29:477-490.

8.

D'Aoust, J. Y., E. Daley, M. Crozier, and A. M. Sewell. 1990. Pet turtles: a
continuing international threat to public health. Am. J. Epidemiol. 132:233-238.

9.

Diaz, M. A., E. C. Achberger, V. R. Srinivasan, and R. J. Siebeling. PlasmidMediated Transfer of High-Level Gentamicin Resistance Among Enterics Isolated from
Pet Turtles in Louisiana. Presented at the 100th American Society for Microbiology
General Meeting. May 2000. Los Angeles, CA, USA.

10.

Diaz, M. A., D. P. Bourgeois, and R. J. Siebeling. Integrons and Gene Cassettes in
Environmental Isolates of Stenotrophomonas maltophilia. Presented at the 102nd
American Society for Microbiology General Meeting. May 2003. Salt Lake City, UT,
USA.

11.

Diaz, M. A., D. P. Bourgeois, and R. J. Siebeling. Prevalence of Integrons and Gene
Cassettes in Environmental Isolates from Louisiana. Presented at the 102nd American
Society for Microbiology General Meeting. May 2003. Salt Lake City, UT, USA.

12.

Diaz, M. A., R. K. Cooper, A. Cloeckaert, and R. J. Siebeling. in press. Plasmidmediated high-level gentamicin resistance in bacteria isolated from turtle farms in
Louisiana. Appl. Environ. Microbiol. 76(1)

13.

Diaz, M. A., M. P. Durham, and R. J. Siebeling. Incidence of Molecular Elements
Involved in the Transfer of Gentamicin Resistance in Environmental Bacteria Isolated
in Louisiana. Presented at the 101st American Society for Microbiology General
Meeting. May 2001. Orlando, FL, USA

14.

Ekperigin, H. E., S. Jang, and R. H. McCapes. 1983. Effective control of a
gentamicin-resistant Salmonella arizonae infection in turkey poults. Avian Dis. 27:822829.

15.

Fluit, A. C., and F. J. Schmitz. 1999. Class 1 integrons, gene cassettes, mobility, and
epidemiology. Eur. J. Clin. Microbiol. Infect. Dis. 18:761-770.
110

16.

Fluit, A. C., and F. J. Schmitz. 2004. Resistance integrons and super-integrons. Clin.
Microbiol. Infect. 10:272-288.

17.

Galimand, M., P. Courvalin, and T. Lambert. 2003. Plasmid-mediated high-level
resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation.
Antimicrob. Agents Chemother. 47:2565-2571.

18.

Galimand, M., S. Sabtcheva, P. Courvalin, and T. Lambert. 2005. Worldwide
disseminated armA aminoglycoside resistance methylase gene is borne by composite
transposon Tn1548. Antimicrob. Agents Chemother. 49:2949-2953.

19.

Greenfield, J., D. J. Sands, C. W. Wood, and K. R. Macdonald. 1975. Comparison
of pressure differential procedures for dipping turkey hatching-eggs in gentamicin
solution. Poult. Sci. 54:1254-1257.

20.

Hall, R. M., H. J. Brown, D. E. Brookes, and H. W. Stokes. 1994. Integrons found in
different locations have identical 5' ends but variable 3' ends. J. Bacteriol. 176:62866294.

21.

Hall, R. M., and C. M. Collis. 1995. Mobile gene cassettes and integrons: capture and
spread of genes by site-specific recombination. Mol. Microbiol. 15:593-600.

22.

Hall, R. M., and H. W. Stokes. 1993. Integrons: novel DNA elements which capture
genes by site-specific recombination. Genetica 90:115-132.

23.

Holmes, A. J., M. R. Gillings, B. S. Nield, B. C. Mabbutt, K. M. Nevalainen, and H.
W. Stokes. 2003. The gene cassette metagenome is a basic resource for bacterial
genome evolution. Environ. Microbiol. 5:383-394.

24.

Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons
reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother.
39:185-191.

25.

Mazel, D., and J. Davies. 1999. Antibiotic resistance in microbes. Cell. Mol. Life Sci.
56:742-754.

26.

Mazel, D., B. Dychinco, V. A. Webb, and J. Davies. 1998. A distinctive class of
integron in the Vibrio cholerae genome. Science 280:605-608.

27.

Michael-Marler, S., M. L. Brown, and R. J. Siebeling. 1983. Eradication of Arizona
hinshawii from artificially infected turtle eggs. Appl. Environ. Microbiol. 45:748-754.

28.

Miller, G. H., F. J. Sabatelli, R. S. Hare, Y. Glupczynski, P. Mackey, D. Shlaes, K.
Shimizu, and K. J. Shaw. 1997. The most frequent aminoglycoside resistance
mechanisms changes with time and geographic area: a reflection of aminoglycoside
usage patterns? Aminoglycoside Resistance Study Groups. Clin. Infect. Dis. 24 Suppl
1:S46-62.

111

29.

NCCLS. 1999. National Committee for Clinical Laboratory Standards.Performance
standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated
from animal. Approved standard (M31-A). Wayne, PA.

30.

Nield, B. S., A. J. Holmes, M. R. Gillings, G. D. Recchia, B. C. Mabbutt, K. M.
Nevalainen, and H. W. Stokes. 2001. Recovery of new integron classes from
environmental DNA. FEMS Microbiol. Lett. 195:59-65.

31.

Partridge, S. R., and R. M. Hall. 2003. In34, a complex In5 family class 1 integron
containing orf513 and dfrA10. Antimicrob. Agents Chemother. 47:342-349.

32.

Partridge, S. R., G. D. Recchia, C. Scaramuzzi, C. M. Collis, H. W. Stokes, and R.
M. Hall. 2000. Definition of the attI1 site of class 1 integrons. Microbiology 146:28552864.

33.

Pembroke, J. T., C. MacMahon, and B. McGrath. 2002. The role of conjugative
transposons in the Enterobacteriaceae. Cell. Mol. Life Sci. 59:2055-2064.

34.

Ploy, M. C., T. Lambert, J. P. Couty, and F. Denis. 2000. Integrons: an antibiotic
resistance gene capture and expression system. Clin. Chem. Lab. Med. 38:483-487.

35.

Rather, P. N., P. A. Mann, R. Mierzwa, R. S. Hare, G. H. Miller, and K. J. Shaw.
1993. Analysis of the aac(3)-VIa gene encoding a novel 3-N-acetyltransferase.
Antimicrob. Agents Chemother. 37:2074-2079.

36.

Rather, P. N., R. Mierzwa, R. S. Hare, G. H. Miller, and K. J. Shaw. 1992. Cloning
and DNA sequence analysis of an aac(3)-Vb gene from Serratia marcescens.
Antimicrob. Agents Chemother. 36:2222-2227.

37.

Recchia, G. D., and R. M. Hall. 1995. Plasmid evolution by acquisition of mobile gene
cassettes: plasmid pIE723 contains the aadB gene cassette precisely inserted at a
secondary site in the incQ plasmid RSF1010. Mol. Microbiol. 15:179-187.

38.

Rowe-Magnus, D. A., A. M. Guerout, and D. Mazel. 1999. Super-integrons. Res.
Microbiol. 150:641-651.

39.

Rowe-Magnus, D. A., and D. Mazel. 1999. Resistance gene capture. Curr. Opin.
Microbiol. 2:483-488.

40.

Saif, Y. M., and S. M. Shelly. 1973. Effect of gentamicin sulfate dip on Salmonella
organisms in experimentally infected turkey eggs. Avian Dis. 17:574-581.

41.

Salyers, A. A., N. B. Shoemaker, A. M. Stevens, and L. Y. Li. 1995. Conjugative
transposons: an unusual and diverse set of integrated gene transfer elements. Microbiol.
Rev. 59:579-590.

42.

Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory
manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.

112

43.

Sandvang, D., F. M. Aarestrup, and L. B. Jensen. 1997. Characterisation of integrons
and antibiotic resistance genes in Danish multiresistant Salmonella enterica
Typhimurium DT104. FEMS Microbiol. Lett. 157:177-181.

44.

Schwocho, L. R., C. P. Schaffner, G. H. Miller, R. S. Hare, and K. J. Shaw. 1995.
Cloning and characterization of a 3-N-aminoglycoside acetyltransferase gene, aac(3)Ib,
from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1790-1796.

45.

Siebeling, R. J., D. Caruso, and S. Neuman. 1984. Eradication of Salmonella and
Arizona species from turtle hatchlings produced from eggs treated on commercial turtle
farms. Appl. Environ. Microbiol. 47:658-662.

46.

Siebeling, R. J., P. M. Neal, and W. D. Granberry. 1975. Treatment of SalmonellaArizona-infected turtle eggs with terramycin and chloromycetin by the temperaturedifferential egg dip method. Appl. Microbiol. 30:791-799.

47.

Stokes, H. W., and R. M. Hall. 1989. A novel family of potentially mobile DNA
elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol.
3:1669-1683.

48.

Stokes, H. W., A. J. Holmes, B. S. Nield, M. P. Holley, K. M. Nevalainen, B. C.
Mabbutt, and M. R. Gillings. 2001. Gene cassette PCR: sequence-independent
recovery of entire genes from environmental DNA. Appl. Environ. Microbiol. 67:52405246.

49.

Sunde, M., and H. Sorum. 1999. Characterization of integrons in Escherichia coli of
the normal intestinal flora of swine. Microb. Drug Resist. 5:279-287.

50.

Tolmasky, M. E. 2000. Bacterial resistance to aminoglycosides and beta-lactams: the
Tn1331 transposon paradigm. Front. Biosci. 5:D20-29.

51.

Vaisvila, R., R. D. Morgan, J. Posfai, and E. A. Raleigh. 2001. Discovery and
distribution of super-integrons among pseudomonads. Mol. Microbiol. 42:587-601.

52.

Vakulenko, S. B., and S. Mobashery. 2003. Versatility of aminoglycosides and
prospects for their future. Clin. Microbiol. Rev. 16:430-450.

53.

Vliegenthart, J. S., P. A. Ketelaar-van Gaalen, and J. A. van de Klundert. 1990.
Identification of three genes coding for aminoglycoside-modifying enzymes by means
of the polymerase chain reaction. J. Antimicrob. Chemother. 25:759-765.

54.

White, P. A., C. J. McIver, and W. D. Rawlinson. 2001. Integrons and gene cassettes
in the Enterobacteriaceae. Antimicrob. Agents Chemother. 45:2658-2661.

113

CHAPTER 5:
OVERALL DISCUSSION AND CONCLUSIONS

114

Salmonella enterica subsp. enterica serovar Enteritidis is the major cause of Salmonella
spp. food poisoning in the U.S., since it is a frequent contaminant of chicken eggs (Cohen,
M.L., et al, 1980; Carattoli, A., 2003). S. enterica subsp. arizonae commonly inhabits the
cloacae of reptiles without causing disease in these animals (Siebeling, R.J., et al, 1975a;
Siebeling, R.J., et al, 1984; Ebani, V.V., et al, 2005). Turtle farming has been an important
economic activity in the state of Louisiana since the 1930s, contributing approximately 30
million dollars to the State’s economy (Siebeling, R.J., et al, 1975b). The tracing of several
salmonellosis outbreaks to pet turtles in the 1970s lead to a domestic ban on the sale of small
carapace turtles in 1975 by the FDA (Siebeling, R.J., et al, 1975a; Cohen, M.L., et al, 1980;
Shane, S.M., et al, 1990). The estimated 300,000 cases of human salmonellosis that could be
traced to pet turtles (Siebeling, R.J., et al, 1975a; Cohen, M.L., et al, 1980), reportedly
accounted for an approximate 14% of Salmonella spp. infections per year (Cohen, M.L., et al,
1980). The domestic ban on the sale of baby turtles did not affect the export market
significantly, which continued to prosper, with 12 million hatchlings being exported from
Louisiana to Western Europe, South America, and Asia every year, accounting for about 90%
of the pet turtle world market (Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984;
Izadjoo, M.J., et al, 1987). However, to guarantee a safe pet for the market, turtle export is
subject to prior testing and certifying hatchlings as Salmonella-spp.-free by independent FDAapproved laboratories, which perform routine bacteriological and molecular assays such as
PCR, before certifying hatchlings for export (Siebeling, R.J., et al, 1984).
Antibiotic use constitutes a selective pressure that favors the growth of bacterial strains
which are resistant, or have acquired resistance, to the particular antibiotic (Davies, J. and
Smith, D.I., 1978; Levy, S.B., 1998; Mazel, D. and Davies, J., 1999; Levy, S.B., 2002). Thus,
the development of gentamicin resistance has been of concern in the agricultural setting,
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particularly in the turkey farm industry, where this antibiotic has been used to eradicate
Salmonella spp. from turkey eggs (Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). The
concern of the emergence of gentamicin-resistant Salmonella spp. has also been voiced for pet
turtles being exported from Louisiana to other countries (D'Aoust, J.Y., et al, 1990). This study
constitutes a report of the molecular causes of the gentamicin resistance problematic in the
turtle farms.
Bacteria that were identified by standard bacteriological assays from the samples taken
at the turtle farms include organisms such as Salmonella enterica subsp. enterica, Salmonella
enterica subsp. arizonae, Enterobacter cloacae, Citrobacter freundii, Stenotrophomonas
maltophilia and Pseudomonas aeruginosa, among others (Chapter 2). These organisms were
found to express high-level resistance to gentamicin. This is of particular concern given that
aminoglycosides are reportedly antibiotics of choice for the treatment of infections from Gramnegative bacteria such as Escherichia coli, Salmonella spp., Shigella spp., Enterobacter spp.,
Citrobacter spp., Acinetobacter spp., Proteus spp., Klebsiella spp., Serratia spp., Morganella
spp., and Pseudomonas spp. (Vakulenko, S.B. and Mobashery, S., 2003).
Bacteria can acquire antibiotic resistance genes from other organisms through
conjugation, transformation and transduction (Mazel, D. and Davies, J., 1999). Moreover,
mobile genetic elements such as transposons, integrons, Gram-positive conjugative transposons
and Gram-negative conjugative transposons, allow bacteria to acquire new genes through
intermolecular genetic exchange (Davies, J. and Smith, D.I., 1978; Stokes, H.W., et al, 2001;
Pembroke, J.T., et al, 2002; Carattoli, A., 2003; Partridge, S.R. and Hall, R.M., 2003). These
mobile DNA elements have played an important role in the evolution of microorganisms
(Recchia, G.D. and Hall, R.M., 1997; Simjee, S. and Gill, M.J., 1997; Hall, R.M., et al, 1999;
Tolmasky, M.E., 2000; Pembroke, J.T., et al, 2002; Rowe-Magnus, A.D., et al, 2002). In this
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study, the majority of the organisms tested for plasmids showed the presence of one or more
plasmids. Some of these plasmids were shown to be conjugative plasmids, as determined by
bacterial mating experiments (Chapter 2) in which plasmids were transfered from
environmental isolates to a laboratory AZI resistant E. coli strain BM14. Transconjugant
organisms were not obtained from all environmental donor strains assayed, as is summarized in
Table 5.1. It is possible that no transconjugants were obtained for donor strains such as
Pseudomonas spp., Stenetrophomonas spp., and Acinetobacter spp., and other non-fermenting
organisms, since they are more distant phylogenetically to the recipient E. coli strain used in
these experiments, than the organisms for which mating experiments were successful, namely,
Salmonella spp., Enterobacter spp., and Citrobacter spp. Consequently, numerous barriers for
conjugation could have taken effect in the former. A scheme illustrating the assays performed
for the transfer of GEN resistance is depicted in Figure 5.1. From these experiments it was
evidenced that the conjugative R-plasmids isolated from all transconjugants and transformants
obtained in this study have relatively large sizes, ranging from ca. 45 to 145 kbp, as can be seen
in Figure 5.2.
Microorganisms can be intrinsically resistant to an antibiotic, or become resistant to the
drug through mutations of the antibiotic target site, or by the acquisition of new resistance
genes (Levy, S.B., 1998; Mazel, D. and Davies, J., 1999; Rowe-Magnus, D.A. and Mazel, D.,
1999). Bacteria can become resistant to antibiotics through a variety of mechanisms, which
include the modification of the antibiotic target, reduced accumulation of the drug within the
cell, and the enzymatic modification of the antibiotic molecule (Davis, B.D., 1987; Levy, S.B.,
1998; Mazel, D. and Davies, J., 1999). The two main modes through which bacteria can
become resistant to aminoglycosides by modifications of the ribosome are through mutations in
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Table 5.1. Conjugative Transfer of GEN Resistance Genes
Donor

Recipient

GmR AziR Transconjugants

Pseudomonas aeruginosa

-

Stenotrophomonas maltophilia

-

Acinetobacter baumanii

-

Proteus vulgaris

E. coli BM14 AziR

Providencia stuartii

-

Salmonella. enterica subsp. enterica

+

Salmonella enterica subsp. arizonae

+

Enterobacter cloacae

+

Citrobacter freundii

+

conjugation

Environmental donor
Sal. enterica
subsp. arizonae

transformation

E. coli BM14 recipient

E. coli TOP10 recipient

Figure 5.1. Diagram of Transfer of GEN resistance
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1

2
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4

5

145 kb
115 kb

45 kb

Figure 5.2. PFGE of R-plasmids isolated from transconjugants
obtained after conjugation with Salmonella enterica subsp.
enterica serovar Enteritidis, Salmonella enterica subsp. arizonae
strains PH5 and A40, Enterobacter cloacae and Citrobacter
freindii. Lane M, PFG molecular size marker; lane 1, plasmid
pSalS5; lane 2, plasmid pAriPH5; lane 3, plasmid pAriA40; lane
4, plasmid pEnt19; lane 5, plasmid pCit14.
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ribosomal proteins or the rRNA and by the enzymatic modification of the ribosome (Davis,
B.D., 1987; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Any
mutation that affects the binding sites of the ribosome can reduce the binding affinity of the
drug to the ribosome and lead to varied levels of resistance. The effects of such mutations
depend on the nature of the mutation and on the chemistry of the drug (Fourmy, D., et al, 1996;
Carter, A.P., et al, 2000; Llano-Sotelo, B., et al, 2002). Nevertheless, it is unlikely that the
organisms investigated in the present study expressed such high-levels of resistance to
gentamicin due to mutations in the target site, the ribosome, since these levels of resistance
were transferable by conjugation in at least some organisms, such as Salmonella spp.,
Enterobacter spp., and Citrobacter spp., as shown in Chapter 2.
The other mode of target site alteration leading to aminoglycoside resistance is through
the enzymatic modification of the ribosome (Davis, B.D., 1987; Cundliffe, E., 1989; Wright,
G.D., et al, 1998). This is a common mechanism used by aminoglycoside producers to protect
themselves from the antibiotics they produce (Cundliffe, E., 1989; Yoshizawa, S., et al, 1998).
Aminoglycoside resistance by enzymatic modification of the ribosome has recently been
detected in bacteria other than antibiotic producers (Galimand, M., et al, 2003; Yokoyama, K.,
et al, 2003; Doi, Y., et al, 2004; Yamane, K., et al, 2004). Usually the activities of most
aminoglycoside modifying enzymes result in effective resistance to aminoglycoside antibiotics,
but only a few phosphotransferase enzymes have been reported to produce high-levels of
resistance to these antibiotics, namely the bifunctional enzyme aph(2”)-aac(6’) (Ferretti, J.J., et
al, 1986), and phosphotransferases aph(2”)Ib, aph(2”)Ic and aph(2”)Id (Galimand, M., et al,
2003; Vakulenko, S.B. and Mobashery, S., 2003). Table 5.2 summarizes the main features of
these enzymes, which confer the HLGR phenotype in Gram-positive organisms. Table 5.3,
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Table 5.2. Aminoglycoside Modifying Enzymes Confering HLGR
Gene

Characteristics

Identified in

Reference

aph(2”)-aac(6’)

- HLGR

Staph. aureus

Ferretti et al (1986)

- Tn4001

streptococci

- IS256

enterococci

- HLGR

Ent. faecium

Kao et al (2000)

- plasmid-encoded

enterococci

Chow et al (1997)

aph(2”)-Ib
-Ic

Tsai et al (1998)

-Id
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Table 5.3. Ribosomal Methyltransferase Enzymes Confering HLAR
Gene

Characteristics

Identified in

Reference

armA

- HLAR

Klebsiella pneumoniae

Galimand et al (2003)

- plasmid-encoded

clinical strain

- 37-47% similarity AG
producers
- low GC content
- aac3-II dhfrXII, sul1,
ant3"9, blaTEM1 and
blaCTX-M
rmtA

- HLAR

Pseudomonas aeruginosa

- plasmid-encoded

clinical strain

Yokoyama et al (2003)

- MIC>1024 mg/L
- 55% GC content
- Tn5041
rmtB

- HLAR

Serratia marcescens

- 82% identity with RmtA

clinical strain

- plasmid-encoded
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Doi et al (2004)

on the other hand, summarizes the characteristics of genes conferring the HLAR phenotype in
Gram-negative organisms.
To the best of our knowledge, there had been no reports in the literature of high-level
resistance to gentamicin in Gram-negative bacteria before this study was started in 1999 (Diaz,
M.A., et al, 2000; Diaz, M.A., et al, in press). On the other hand, there had been an abundance
of reports on high-level gentamicin resistance for Gram-positive bacteria (Chow, J.W., 2000).
To be effective, aminoglycosides must first penetrate the cell wall and membranes and
reach their target, the bacterial ribosome (Bryan, L.E. and Van Den Elzen, H.M., 1977; Martin,
N.L. and Beveridge, T.J., 1986; Davis, B.D., 1987). Some microorganisms can inhibit this
important step of the aminoglycoside mode of action, particularly the pseudomonads and other
non-fermentor Gram-negative bacilli (Bryan, L.E. and Van Den Elzen, H.M., 1977; Martin,
N.L. and Beveridge, T.J., 1986). This mechanism of reduced uptake of the drug is generally
due to membrane impermeabilization, which impairs drug penetration into the cell (Bryan, L.E.
and Van Den Elzen, H.M., 1977; Davis, B.D., 1987) and results in an intermediate
susceptibility to all of the aminoglycosides (Miller, G.H., et al, 1997; Lister, P.D., 2002). In
addition, adaptive resistance to aminoglycosides is often reported for aerobic Gram-negative
bacilli, such as Pseudomonas spp. (Davis, B.D., 1987; Wright, G.D., et al, 1998). This
resistance is thought to be due to regulatory events rather than mutations or the acquisition of
resistance genes, so it does not persist once the selective pressure is removed (Karlowsky, J.A.,
et al, 1996). We do not discount the possibility that this mechanism may contribute to the
multiple drug resistance phenotypes displayed by the non-fermenting organisms identified in
this study (Chapters 2 and 3). This could act in synergy with the expression of the resistance
gene aac(3)IIa detected in the majority of these organisms.
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Another mechanism of reduced accumulation of an antibiotic within the bacterial cell is
through the active efflux or pumping of the drug out of the cell (Zgurskaya, H.I. and Nikaido,
H., 2000), which is more frequently observed in non-fermentor Gram-negative bacilli (Martin,
N.L. and Beveridge, T.J., 1986; Westbrock-Wadman, S., et al, 1999), but has also been
reported in Samonella spp. and E. coli (Nikaido, H., et al, 1998; Rosenberg, E.Y., et al, 2000).
Multidrug efflux pumps can be acquired as foreign genes, or alternatively, the reduced
accumulation of an antibiotic can be due to the activation or the increased expression of an
innate efflux system (Westbrock-Wadman, S., et al, 1999; Putman, M., et al, 2000; Zgurskaya,
H.I. and Nikaido, H., 2000; Lister, P.D., 2002). Although multidrug efflux pumps generally
have low substrate specificities (Zgurskaya, H.I. and Nikaido, H., 2000), some studies have
reported efflux pumps that pump aminoglycosides out of the cell (Aires, J.R., et al, 1999;
Rosenberg, E.Y., et al, 2000; Mao, W., et al, 2001). Furthermore, the presence of different
efflux pumps may confer additive or multiplicative effects on drug resistance (Lee, A., et al,
2000).
In this study, it is improbable that the high-level gentamicin resistance observed in
bacteria other than non-fermentors is due to the activation of innate efflux pumps, since this
phenotype was transferable through conjugation and transformation, suggesting the genes are
plasmid-borne. It is possible that this mechanism can account for the multiple antibiotic
resistance phenotypes observed in the non-fermenting organisms, but further studies are
necessary to ascertain such information. While in this study we did not detect (Chapter 2) a
plasmid-encoded efflux pump which could be transferred among the organisms in the turtle
farm environment, this possibility is not entirely discarded and should be tested in the future
using aminoglycoside accumulation assays.
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By far the most important mechanism of aminoglycoside resistance is the enzymatic
modification of the drug by aminoglycoside modifying enzymes, resulting in a molecule with
decreased binding affinity to the ribosome (Wright, G.D., et al, 1998; Vakulenko, S.B. and
Mobashery, S., 2003). The largest group of these enzymes, the aminoglycoside
acetyltransferases,

participate

in

the

acetylCoA-dependent

acetylation

of

specific

aminoglycoside amino groups (Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Azucena, E.
and Mobashery, S., 2001; Vakulenko, S.B. and Mobashery, S., 2003). Aminoglycoside
modifying enzymes display substrate specificity, which means that each enzyme will modify a
specific chemical group, resulting in a particular phenotype (Shaw, K.J., et al, 1993; Wright,
G.D., et al, 1998).
According to the nomenclature proposed by K.J. Shaw et al, (Shaw, K.J., et al, 1993),
AAC(3)IIa is an acetyltransferase enzyme which participates in the addition of an acetyl group
to the amino group at position 3 of the 2-deoxystreptamine ring of the aminoglycoside
molecule, giving resistance profile “II” by gene a (Shaw, K.J., et al, 1993; van de Klundert,
J.A. and Vliegenthart, J.S., 1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery,
S., 2003). Enzyme AAC(3)VIa uses the acetyl group from an acetyl coenzyme-A donor
molecule to modify the aminoglycoside molecule at the position 3 of the 2-deoxystreptamine
ring, and confers resistance profile VI, by gene a (Shaw, K.J., et al, 1993; Vakulenko, S.B. and
Mobashery, S., 2003).
The AAC(3)-II resistance pattern phenotype reportedly involves resistance to
gentamicin, tobramycin, sisomicin, netilmicin, and dibekacin (Shaw, K.J., et al, 1993; Miller,
G.H., et al, 1997; Vakulenko, S.B. and Mobashery, S., 2003) whereas AAC(3)-VI includes
resistance to gentamicin (Shaw, K.J., et al, 1993; Miller, G.H., et al, 1997; Diaz, M.A., et al,
2000; Diaz, M.A., et al, 2001; Vakulenko, S.B. and Mobashery, S., 2003). Though each
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aminoglycoside modifying enzyme presents substrate specificity, the antibiotic resistance
phenotype alone cannot be used in a study to determine the gene confering this resistance since
there may be cumulative effects from multiple enzymes (Shaw, K.J., et al, 1993; Miller, G.H.,
et al, 1997). Thus, in this study, the problem was approached by cloning and sequencing of the
genes which conferred gentamicin resistance to bacteria isolated at the turtle farms and which
were transfered by conjugation and transformation to naïve E.coli. As discussed in Chapter 2,
these experiments lead to the identification of genes aac(3)IIa and aac(3)VIa (Diaz, M.A., et
al, in press).
The gene aac(3)IIa was originally identified in R-plasmids in Enterobacteraceae
(Allmansberger, R., et al, 1985), as well as aac(3)VI, originally cloned from a conjugative
plasmid of Enterobacter cloacae. The enzymes encoded by these genes reportedly share 50%
amino acid identity (Rather, P.N., et al, 1993; Vakulenko, S.B. and Mobashery, S., 2003). In
effect, all gentamicin resistant organisms tested in this study were positive for either one of the
two aac(3) genes detected in the cloning and sequencing of gentamicin resistance determinants.
These genes were detected in quite diverse organisms from the turtle farms, which were also
different from the organisms originally reported on (Brau, B., et al, 1984; Allmansberger, R., et
al, 1985; Rather, P.N., et al, 1993). Furthermore, each of these genes were found to be encoded
on different plasmids, as shown in Chapter 2, all of which supports their dissemination through
mobile molecular elements.
In this regard, it is relevant to state that when we began this study, only gene aac(3)VIa
had been reported to be encoded as a gene cassette in a class-1 integron (Brau, B., et al, 1984;
Allmansberger, R., et al, 1985; Rather, P.N., et al, 1992; Rather, P.N., et al, 1993; Diaz, M.A.,
et al, 2000; Diaz, M.A., et al, 2001). Integrons are gene-capture molecular elements that
contain an integrase gene, named intI, and an arrangement of gene cassettes which are
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expressed from a common promoter (Stokes, H.W. and Hall, R.M., 1989; Collis, C.M. and
Hall, R.M., 1995) and which are often found on the plasmids and/or the chromosomes of
Gram-negative bacteria (Hall, R.M. and Stokes, H.W., 1993; Recchia, G.D. and Hall, R.M.,
1997; Fluit, A.C. and Schmitz, F.J., 1999; Hall, R.M., et al, 1999; Rowe-Magnus, D.A. and
Mazel, D., 1999; White, P.A., et al, 2001). The majority of gene cassettes described to date
code for antibiotic resistance (Fluit, A.C. and Schmitz, F.J., 1999; Fluit, A.C. and Schmitz, F.J.,
2004) and are thus known as multiple resistance integrons or MRIs. (Recchia, G.D. and Hall,
R.M., 1995; Fluit, A.C. and Schmitz, F.J., 1999; Mazel, D. and Davies, J., 1999).
Four different classes of integrons had been identified before 2001, according to the IntI
integrase and the general gene arrangement that they encode, namely, class-1 (Stokes, H.W.
and Hall, R.M., 1989), class-2, class-3 (Collis, C.M., et al, 2002) and class-4 (Mazel, D., et al,
1998). The main distinguishing features of integron classes, other than class-1, are summarized
in Table 5.4. In this study, we detected the presence of the integrase gene of integron class-1
associated with the gene aac(3)VIa. In effect, all isolates carrying this gene were also positive
by PCR to intI1 (Chapter 2). However, isolates carrying aac(3)IIa were not intI1-positive by
this assay, with the primer set described in Chapter 2.
The larger type of integrons, referred to as “super-integrons” or SIs and originally
described in Vibrio cholerae (Mazel, D., et al, 1998; Rowe-Magnus, D.A., et al, 1999; RoweMagnus, D.A. and Mazel, D., 1999; Clark, C.A., et al, 2000) are also found as components of
the genomes of many γ-proteobacteria, such as Xanthomonas spp., Shewanella spp. and
Pseudomonas spp. (Rowe-Magnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D.,
1999; Vaisvila, R., et al, 2001). On the other hand, though the sequences which flank gene
cassettes can vary greatly between different integron classes (Hall, R.M., et al, 1994; Stokes,
H.W., et al, 1997; Stokes, H.W., et al, 2001), identical gene cassettes have been found to be
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Table 5.4. General Characteristics of Integrons Class II, III and IV
Class II
- Included in the family of
Tn7 transposons

Class III

Class IV

- Only one described to date

- Presence of Tn7
transposition genes

- Super-integron (SI) or
‘integron island’
- First described in Vibrio
cholerae

- a defective integrase gene
intI2, located at 5’CS

- Integrase gene intI3 has
61% homology with intI1

- Integrase gene intI4

- 3 integrated gene cassettes:
dhfrI-sat-aadA1

- contains gene cassette
blaIMP

- ~ 100 gene cassettes

- No sulI gene

- Presence of a part of gene
aacA4

- att site located between
gene intI2 and 1st
resistance gene, as in class
I integrons.

- Atypical recombination
sites around gene cassette
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- gene cassettes encoded
may have virulence
functions (not antibiotic
resistance)

Other classes
- Only the integrases
detected, from
environmental DNA

- intI5, intI6, intI7 …

encoded in integrons of different classes, which indicates that the gene cassette pool may be
shared between them (Fluit, A.C. and Schmitz, F.J., 1999; Rowe-Magnus, D.A. and Mazel, D.,
1999; Rowe-Magnus, D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, F.J., 2004).
In this study, we detected the presence of aac(3)IIa in different plasmids and diverse
bacterial genera of organism, so it was hypothesized that the gene was encoded within a mobile
molecular element such as another integron besides class-1, possibly even a superintegron as
described in Xanthomonas spp., and Pseudomonas spp. (Rowe-Magnus, D.A., et al, 1999;
Rowe-Magnus, D.A. and Mazel, D., 1999; Vaisvila, R., et al, 2001). For this reason we
screened for the presence of putative integrase (Nield, B.S., et al, 2001) and gene cassette
(Stokes, H.W., et al, 2001) genes, using degenerate primers designed to detect these elements
in DNA from environmental bacteria (Nield, B.S., et al, 2001; Stokes, H.W., et al, 2001).
These assays, though numerous and quite extensive (Diaz, M.A., et al, 2002b; Diaz, M.A., et
al, 2002a), did not lead to detection of an integrase or gene cassette from the isolates studied.
Thus, this screening strategy which proved useful in detecting new integrases and gene
cassettes from the environment in Australia (Stokes, H.W., et al, 2001), was quite unfruitful in
this study, as well as others (J. Davies, personal communication). Nevertheless, this approach
and others which involve the molecular screening for antibiotic resistance genes is important
and should be pursued, as many of the organisms that help maintain antibiotic resistance gene
pools are not necessarily cultivable, and thus escape detection through classic antimicrobial
testing, as seen in Chapter 3 .
Class-1 integrons are the most prevalent integrons among clinical isolates (Hall, R.M.
and Stokes, H.W., 1993; Fluit, A.C. and Schmitz, F.J., 1999). Their basic structure is
characterized by the presence of two conserved sequences, known as the 5’-CS and 3’-CS,
which flank a variable region. The 5'-conserved region contains the integrase gene intI1 and a
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gene cassette attachment site, attI. The 3'-conserved region is characterized by the presence of a
sulfonamide resistance gene, sul1, a quaternary ammonium compound resistance gene, qacE∆1
and open reading frames orf5 and orf6, with unknown functions (Stokes, H.W. and Hall, R.M.,
1989; Hall, R.M. and Stokes, H.W., 1993). These conserved regions have proven useful to
design primers that allow the detection of gene cassette arrangements encoded within the
variable region of class-1 integrons (Levesque, C., et al, 1995; Sandvang, D., et al, 1997). This
variable region of class-1 integrons can code for one or more gene cassettes (Stokes, H.W. and
Hall, R.M., 1989; Hall, R.M. and Stokes, H.W., 1993). In this study, we used these published
5’CS-3’CS primers (Sandvang, D., et al, 1997) to screen for the presence of different gene
arrays in the isolates under study. This lead to the detection of the expected gene cassettes from
organisms known to be carrying gene aac(3)VIa within a class-1 integron, but interestingly, we
also obtained amplicons for organisms which had been negative for intI1 (Chapter 2) and which
carried gene aac(3)IIa.
Gene cassettes can be exchanged between the different integron classes, which supports
the notion that they may have played an important role in bacterial evolution (Rowe-Magnus,
D.A. and Mazel, D., 1999; Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel,
D., 2001; Rowe-Magnus, D.A., et al, 2002; Holmes, A.J., et al, 2003). In effect, the genetic
flexibility that integrons confer bacteria allows them to adapt rapidly to environmental
challenges by allowing bacteria to acquire favorable genes that can result in an improved
fitness as well as eliminate those that prove useless (Hall, R.M., et al, 1999; Rowe-Magnus,
D.A. and Mazel, D., 1999; Rowe-Magnus, D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz,
F.J., 2004). On the other hand, even though the majority of the cassettes in the SIs are not
expressed, they are believed to be maintained in the absence of selective pressure as a genetic
resource for the evolution of new genes (Rowe-Magnus, D.A. and Mazel, D., 1999; Rowe130

Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 2001; Rowe-Magnus, D.A., et
al, 2002; Holmes, A.J., et al, 2003).
There is great variability in the level of expression of genes encoded as gene cassettes.
This can be due to intrinsic characteristics of both the gene cassettes and the integron
(Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995; Hall, R.M. and Collis, C.M.,
1995; Recchia, G.D. and Hall, R.M., 1995). Gene cassettes are inserted in integrons in the same
orientation to their coding sequence, with their initiation codons located near their 5’ end (Hall,
R.M. and Collis, C.M., 1995). Generally, gene cassettes do not code a promoter of their own,
but are rather expressed from a common promoter, Pant or P1, or rarely from P2 (Levesque, C.,
et al, 1994; Collis, C.M. and Hall, R.M., 1995; Stokes, H.W., et al, 2001). Both P1 and P2
promoters are located in the 5’-conserved segment (5’-CS) of class 1 integrons. P1 is located in
a region 200 bp upstream from the genes-cassettes inserted at the attI1 site (Levesque, C., et al,
1994; Collis, C.M. and Hall, R.M., 1995).
Several factors can affect the expression of the gene cassettes in an integron (Ploy,
M.C., et al, 2000). The P1 promoter sequence has strong sequence similarity to the E. coli
promoter consensus sequence. Studies on integron promoter sequences support that variations
in the sequence of P1 can significantly affect the level of expression of a given gene (Levesque,
C., et al, 1994; Collis, C.M. and Hall, R.M., 1995). In this study, we did not detect any
mutation which could have an effect on the expression of the gentamicin resistance gene
cassettes.
Another factor which can significantly affect the expression of gene cassettes is the
order in which the cassette is inserted in the integron. Thus, the level of resistance conferred is
higher for the resistance genes that are located in the first place, i.e. the first cassette. Likewise,
it is reduced when there are preceding cassettes (Levesque, C., et al, 1994; Collis, C.M. and
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Hall, R.M., 1995; Ploy, M.C., et al, 2000). In this sense, it is not surprising to have found in
this study gene aac(3)VIa to be in the first position in the array of gene cassettes, near the
integrase gene.
As stated before, when we began this study, only the gene aac(3)VIa had been reported
as a gene cassette within a class-1 integron. In our preliminary work, we had detected integron
elements in bacteria carrying the aac(3)IIa gene as well (Diaz, M.A., et al, 2002b; Diaz, M.A.,
et al, 2002a; Diaz, M.A., et al, in press). However, recent studies by others have also depicted
the aac(3)II gene to be surrounded by integron elements (Galimand, M., et al, 2003). In fact,
the molecular environment of the armA gene has been depicted as a composite or complex
class 1 integron environment (Partridge, S.R. and Hall, R.M., 2003). Complex class 1
integrons, as the classical class 1 integrons, possess a 5’-conserved sequence (5’-CS) encoding
an integrase gene and a gene cassette attachment site, attI. The variable sequence can encode
one or more resistance gene cassettes. Then, instead of a single 3’-conserved sequence, there
are two 3’-conserved sequences: 3’-CS1 and 3’-CS2, both of which encode quaternary
ammonium compound gene qacE∆1 and sul1. The 3’-CSs are spanning a conserved region,
CR, and a unique region. The CR typically encodes orf513, encoding a putative recombinase,
and a potential recombination site. The unique region generally encodes resistance genes,
which are not encoded as gene cassettes. The general structure of complex integrons is
presented in Figure 5.3 (Partridge, S.R. and Hall, R.M., 2003; Doublet, B., 2004).
This type of arrangement has been described in other organisms, involving a mobile
integrative structure known as a conjugative transposon (Salyers, A.A., et al, 1995; Partridge,
S.R. and Hall, R.M., 2003), which could further contribute to its dissemination. Conjugative
transposons are DNA elements that can excise themselves to form a covalently closed circular
intermediate (Salyers, A.A., et al, 1995). This intermediate can then reintegrate itself within the
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same organism or, it can be transfered by conjugation to a recipient cell and then integrate in
the recipient’s genome (Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002; Partridge, S.R.
and Hall, R.M., 2003). First found in Gram-positive bacteria such as the streptococci and
enterococci (Tolmasky, M.E., 2000) and barely mentioned before 1996 in Gram-negative
bacteria (Pembroke, J.T., et al, 2002), conjugative transposon-like elements have later been
detected in Gram-negative bacteria such as Bacteroides spp. (Salyers, A.A., et al, 1995;
Pembroke, J.T., et al, 2002) and though characterized in a lesser extent, in the
Enterobacteriaceae. They have been reported in Salmonella spp., Proteus spp., in the SXT
element in Vibrio spp. and in the element known as R391 (Salyers, A.A., et al, 1995;
Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, R.M., 2003).
Because the aac(3)IIa gene product was not reported to confer high-level gentamicin
resistance, we hypothesized in the first stages of our studies that we would find a second gene
which could act in synergy with the already identified genes to confer high-level gentamicin
resistance to several members of the Enterobacteriaceae that we had isolated in our
laboratories and which displayed the HLGR phenotype (Diaz, M.A., et al, 2000; Diaz, M.A., et
al, in press). We redirected our study following a recent report that high-level aminoglycoside
resistance in a clinical strain of Klebsiella pneumoniae was due to the presence of armA, a new
aminoglycoside resistance methylase gene with only 37-47% similarity to the 16S rRNA
methyltransferases from actinomycetes (Galimand, M., et al, 2003). This strain also presented
genes aac(3)II, blaTEM1, blaCTX-M, dfrA12, sul1 and ant(3")9, conferring resistance to
aminoglycosides, β-lactams, trimethroprim, sulfonamides and streptomycin-spectinomycin,
respectively. Other genes conferring high-level aminoglycoside resistance in Gram-negative
bacteria have been found in a Japanese clinical isolate of Pseudomonas aeruginosa AR-2
(Yokoyama, K., et al, 2003) and Serratia marcescens (Doi, Y., et al, 2004), namely, methylase
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enzymes rmtA and rmtB (Doi, Y., et al, 2004; Yamane, K., et al, 2005). The GC content of
these genes and functional analysis of these enzymes support a possible horizontal gene
transfer from aminoglycoside-producing microorganisms (Yokoyama, K., et al, 2003; Doi, Y.,
et al, 2004; Yamane, K., et al, 2005). In this study, in spite of quite numerous PCR, cloning and
sequencing assays performed with the aim of identifying any of these methylase enzymes in the
isolates obtained from the turtle farm environment, we did not obtain any amplicon which,
upon its sequencing, confirmed the presence of any of these methylase-encoding genes in our
isolates.
Interestingly, when we screened for other genes associated with the reported methylase
genes (Galimand, M., et al, 2003; Galimand, M., et al, 2005), we obtained amplification of the
intI1 gene for isolates containing gene aac(3)IIa. As mentioned before, this is in contradiction
with what we had obtained using a different primer set, mentioned in Chapter 2. It is then
possible that gene aac(3)IIa is carried by a complex integron and thus was not detected as such
with the primer pair used to detect the classic structure of integron class-1. The general
structure of complex integrons is illustrated in Figure 5.3 (Partridge, S.R. and Hall, R.M.,
2003; Doublet, B., 2004). Sequencing of regions encoding gene cassettes will shed light in this
regard (Chapter 4) (Levesque, C., et al, 1995; Sandvang, D., et al, 1997; Sunde, M. and Sorum,
H., 1999; Nield, B.S., et al, 2004). Interestingly, recent investigations have found integronencoded ribosomal methylase genes (Nield, B.S., et al, 2004).
In conclusion, there are two genes which contribute to the high-level gentamicin
resistance in bacteria isolated from sites with turtle farming activity in Louisiana. These genes
are aac(3)IIa and aac(3)VIa, which code for aminoglycoside acetyl-transferase enzymes. These
confer resistance to various aminoglycosides and were detected on different conjugative
plasmids. The resistance genes detected in bacteria recovered from environmental samples with
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sul1
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turtle farming activity are coded on class-1 integrons . The molecular environment differed
amongst the diverse isolates, which supports their presence on molecular gene exchange
elements. Thus, transfer of these genes may involve a complex class-1 integron. Further studies
of their molecular environment are required in order to detect and characterize such mobile
structures.
This work constitutes one of the first reports of high-level gentamicin resistance in
Gram-negative bacteria. It is one of the first to report aminoglycoside resistance genes
aac(3)IIa and aac(3)VIa in environmental isolates of Salmonella enterica subsp. arizonae.
Additionally, this study illustrates the potential of transfer of antibiotic resistance genes,
particularly gentamicin resistance, among bacteria in an environment with turtle farming
activity, a matter of particular concern as it involves the human pathogen Salmonella spp. This
research provides epidemiological data of resistance to aminoglycosides currently used both in
the turtle farms and in the clinical setting. The data presented highlights the current inefficacy
of the antibiotic gentamicin to eradicate Salmonella spp. from turtle eggs. We hope to persuade
the relevant authorities in Louisiana to revise the mandate of using gentamicin for turtle egg
treatment, and to stress the need to develop new treatments to eradicate Salmonella spp. from
turtle hatchlings.
This work does not undermine the value of antibiotic use. It does, however, intend to
emphasize the importance of monitoring the inevitable emergence of antibiotic resistance, so its
appropriate implementation can be redirected accordingly. It is a process in flux, far from being
static, which involves continuous vigilance, and surveillance. Ultimately, one of the solutions
with the highest impact on antibiotic resistance is the adequate education of people who use
them, at any level.
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Real-time PCR, also referred to as Q-PCR, is a variation of the PCR assay in which the
exact amount of PCR amplification products can be monitored as it is being made. This is in
part due to the properties of the fluorescent molecules used to track these products. One of
these molecules, SyberGreen, binds to DNA with much higher affinity for double-stranded than
single-stranded DNA. In addition, when bound to double-stranded DNA, SyberGreen
fluoresces, which is detected by the spectrophotometer built into the thermocycler, thus
monitoring the formation of PCR product as it is being made, or in real time.
In this study, real-time PCR was standardized to detect gene aac(3)IIa. Primers
designed within conserved sequences of the rrn gene were used to amplify part of the
ribosomal gene as a control or reference (Chapter 2). The primers used to amplify gene
aac(3)IIa were designed using the Beacon Designer 2.0 software (Biosoft International, Palo
Alto, CA). Genomic DNA used for all reactions was obtained from a strain of Salmonella
enterica subsp. enterica which was positive by conventional PCR and sequencing to gene
aac(3)IIa (Chapter 2).
The figures included in this Appendix show the suitability of all primers designed to
amplify genes aac(3)IIa and rrn. SybrGreen (SYBR-490) was used as the fluorescein molecule
to track the real-time progression of all Q-PCR reactions. Figure A.1., Figure A.4., and Figure
A.6. show the melting curve graphs for genes aac(3)IIa and rrn using SYBR-490. It is evident
from these figures that the primer sets designed produce only one amplicon in each case. In
effect, melting points for aac(3)IIa gene amplicons are all at 86oC and those for rrn gene
amplicons are all at 88oC. Two much smaller curves, in blue and red, which peak around
82.5oC, correspond to the primer controls in which no DNA was added, and evidence the
suitability of primers designed for real-time PCR.
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Figure A.5. and Figure A.7. present results from real-time PCR graphs for genes
aac(3)IIa and rrn, as obtained by using SYBR-490. These graphs show the logarithmic plot of
real-time PCR through all cycles. The CT values can be seen intersecting the orange horizontal
line, which was set at a point where all PCR reactions were linear. From these graphs, it is
evident that different DNA concentrations intersect the horizontal line after different amounts
of cycles, as is expected. Thus, the more diluted the sample, the more cycles it takes to reach a
certain product quantity. In addition, all replicas intersect the horizontal line at the same
number of cycles. Furthermore, primer controls, where no DNA was added, can be seen to the
far right in red and blue, and show that no significant amplification is detected throughout PCR
cycles. Thus, this is an accurate measurement of the amount of aac(3)IIa and rrn amplicons in
a particular sample.
Standard curves were done with 1:10 serial dilutions of Genomic DNA. Figure A.2.
and Figure A.3. show the standard curves obtained when plotting SYBR-490 values with the
dilutions of the DNA assayed, throughout the progression of PCR cycles. The high correlation
coefficients obtained in both curves indicate that both primer pairs designed can be
appropriately used for the quantitation of gene aac(3)IIa from unknown samples. Because the
amount of gene rrn does not vary within a particular bacterial strain, differences in rrn
quantities will account for any variation due to experimental manipulation or error. Thus, it can
be used as a reference to compare against variations in aac(3)IIa amounts. With this
methodology, variations in the number of aac(3)IIa, following exposure to different treatments,
could be measured. Furthermore, the expression of this gene could also be monitored, using
these same primers and conditions, but using total bacterial cDNA as template DNA. This
Appendix includes data from experiments unfinished as of yet and which will be published as a
communication of a technique standardization.
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aac(3)IIa
rrn

Figure A.1. Melt Curve Graph for Genes aac(3)IIa and rrn, Using SYBR-490

Figure A.2. Standard Curve Graph for Gene aac(3)IIa, Using SYBR-490

Figure A.3. Standard Curve Graph for Gene rrn, Using SYBR-490
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Figure A.4. Melt Curve Graph for Gene aac(3)IIa, Using SYBR-490

Figure A.5. Real Time PCR Graph for Gene aac(3)IIa, Using SYBR-490
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Figure A.6. Melt Curve Graph for Gene rrn, Using SYBR-490

Figure A.7. Real Time PCR Graph for Gene rrn, Using SYBR-490
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